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ABSTRACT
Individuals with mild neurocognitive disorder complete many activities of daily living
independently; however, they may require the use of compensatory strategies while performing
everyday tasks. Compensatory strategies, such as external memory aids, incorporate a strengthsbased approach to enhance the functional needs of individuals. Although external memory aids
have a strong evidence-base, limited assessment tools and interventions are available to facilitate
the development of individualized treatment plans that promote sustained strategy use. To better
support the everyday needs of individuals with mild neurocognitive disorder and to inform
clinicians who are developing interventions, the current dissertation includes four paper that
examine a functional framework for external memory aid assessment and intervention. The first
paper examined a group intervention teaching three types of external memory aids on functional
strategy use, perceived strategy use, and cognitive skills. The second paper identified individual
preferences for experiences with external memory aids during and following intervention. The
third paper examined individual changes in functional and perceived strategy use following a
group-based intervention teaching external memory aids. Lastly, the fourth paper examined the
content validity and internal structure of the Functional External Memory Aid Tool: a measure
that explores external memory aid use with simulated everyday tasks. By understanding the
weaknesses in currently used assessment and intervention practices and the unique preferences
of clients, this multi-manuscript dissertation aims to enhance the immediate and long-term needs
of individuals with mild neurocognitive disorder.

vii

CHAPTER ONE: INTRODUCTION
Many individuals with mild neurocognitive disorder demonstrate a change in cognition
that interferes with performing everyday tasks to the same speed and efficiency as typically
aging peers (Petersen, 2004). These cognitive changes are associated with decreased memory
skills that effect encoding, storing, and accessing information necessary to recall and execute
complex activities of daily living (Hickey & Bourgeois, 2018). In some individuals, these
cognitive impairments may progress to a formal diagnosis of dementia (Petersen, 2004).
Therefore, focusing assessments and interventions at the impairment level for these individuals is
not recommended (Holland, 2003). Rather, assessment and treatment plans need to identify and
address strengths and weaknesses according to the functioning level, which is consistent with the
World Health Organization’s (WHO) International Classification of Functioning, Disability, and
Health (WHO, 2001).
According to the WHO-ICF model (2001), an individual’s functioning level (e.g.,
participation in everyday activities) represents the interaction among the personal, social
perspective, and impairment factors. Therefore, assessments and interventions for individuals
with mild neurocognitive disorder must maximize participation in daily life that is both
meaningful and satisfying for the client (Hickey & Bourgeois, 2018).
Compensatory-based interventions, such as external memory aids, support an individual’s
functioning level because the focus is on developing and teaching strategies that compensate for
cognitive impairments (Bourgeois, 2013; Sohlberg & Mateer, 2001). External memory aids
1

compensate for memory impairments by taking advantage of the individual’s remaining abilities
to encode and retrieve information needed to complete daily tasks. Both the American SpeechLanguage and Hearing Association (2005) and American Psychiatric Association (2013) have
emphasized the importance of developing and using compensatory strategies to enhance
independence for individual with mild neurocognitive disorder.
Unfortunately, limited guidance exists to support clinicians in focusing specifically on
developing and teaching external memory aids throughout the assessment and intervention
phases of care for individuals with mild memory impairments. Most assessment tools available
for professionals to use are impairment-based tests and provide limited information on
performance of individual strategies that might inform individualized treatment plans (Hickey &
Bourgeois, 2018). In addition, external memory aids are commonly taught during intervention in
combination with other cognitive strategies without consideration of the unique personal and
environmental factors that may impact sustained use (Greenaway, Duncan, & Smith, 2012;
Kinsella et al., 2009). Although these strategies facilitate independent performance of everyday
tasks, external memory aids are rarely maintained following intervention (Scherer, 2009).
Therefore, additional research is needed to address these limitations to improve the gaps between
external memory aid assessment and the development of individualized interventions.
The purpose of this multi-manuscript dissertation is to examine the effects of
restructuring external memory aid assessment and intervention on the performance of everyday
tasks for individuals with mild neurocognitive disorder. The first paper examined a group
intervention teaching three categories (i.e., calendars, timers, and personal information) of
external memory aids on functional strategy use, perceived strategy use, and cognitive skills. The
2

second paper identified individual external memory aid preferences following intervention and
treatment experiences during intervention. The third paper examined individual changes in
functional and perceived strategy use following a structured intervention teaching external
memory aids across four weeks. The fourth paper examined the content validity and internal
structure of the Functional External Memory Aid Tool.
By restructuring current compensatory assessment and intervention practices,
professionals will enhance the functional needs of individuals with mild neurocognitive disorder.
Using this new approach, we can begin to develop a proactive and functional model for
assessment and intervention that will possibly enhance the current skills of individuals and
facilitate sustained strategy use following intervention.
References
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CHAPTER TWO: GROUP EXTERNAL MEMORY AID TREATMENT FOR MILD
COGNITIVE IMPAIRMENT
Note to Reader
Portions of this chapter have been previously published in Aphasiology, 2018, 33(3):
320-336, and have been reproduced with permission from Taylor & Francis Group.
Introduction
Mild Cognitive Impairment
Approximately twenty percent of older Americans are currently living with mild cognitive
impairment (MCI; Roberts & Knopman, 2013). People with MCI experience changes in memory
that are greater than expected due to normal aging; however, their ability to complete basic
activities of daily living remains relatively intact (Petersen, 2004). MCI is now included within
Neurocognitive Disorder (NCD), according to the DSM-V (American Psychiatric Association,
2013). The DSM-V distinguishes between mild and major NCD classification based on cognitive
impairment and completion of activities of daily living. Although people within the mild
classification often live independently, they may require compensatory strategies to maintain
social relationships and complete cognitive communication tasks. Individuals with MCI
primarily have impairments in short-term memory; however, communication difficulties are
often observed (Constantiniduo, Wertheimer, Tsanadis, Evans, & Paul, 2012; Doty, 2007;
Johnson & Lin, 2014). Limited research exists to guide clinicians working with these individuals
to support cognitive communication impairments.
Cognitive interventions for individuals with memory impairments include compensatory
5

and restorative approaches. Most of these approaches were developed for individuals with
dementia or traumatic brain injury; only recently, cognitive interventions have been adapted for
individuals with MCI. Researchers have evaluated the changes in cognition, function, and quality
of life following a variety of cognitive interventions for individuals with MCI. Systematic
reviews (Jean, Bergeron, Thivierge, & Simard, 2010; Stott & Spector, 2011) revealed that most
of the reviewed studies involved instruction for internal (e.g., mnemonics) or external (e.g.,
calendar) memory strategies. Several studies concluded that individuals with MCI could learn
compensatory memory strategies (Troyer, Murphy, Anderson, Moscovitch, & Craik, 2008).
Instruction in the use of external strategies resulted in greater improvements in functional tasks
for individuals with MCI than those who received instruction in the use of internal strategies
(Stott & Spector, 2011).
External Memory Aids
Many types of external memory aids (EMAs) exist; such as, weekly planners, written
schedules, calendars, and timers to support memory, and notebooks, memory wallets, and log
books to support communication impairments (Bourgeois, 2013; Garrett & Yorkston, 1997;
Hersch & Treadgold, 1994; Sohlberg & Mateer, 2001). When provided with appropriate
instruction, EMAs allow individuals to compensate for their cognitive communication
impairments in daily activities (Sohlberg & Mateer, 2001). Early instruction in EMAs is likely
beneficial for people with MCI, because their procedural memory is relatively intact enhancing
the opportunity to learn a new skill (Constantinidou et al., 2012).
Successful use of EMAs requires systematic evidence-based instruction in their
functional use. Existing studies have mostly investigated interventions for the use of multiple
strategies instead of only instruction in the use of EMAs. Kinsella et al. (2009) examined the
6

effectiveness of a problem-solving approach for memory impairments delivered via group
treatment for 52 participants diagnosed with MCI. The participants learned across five sessions
about memory as a multifactorial construct, EMAs, strategies for organizational and attention
skills, as well as internal memory aids and general coping strategies. Following group treatment,
the participants increased their knowledge and use of memory strategies as indicated on the
Multifactorial Memory Questionnaire (MMQ; Troyer & Rich, 2002). The researchers measured
prospective memory using the Reminder Task and Envelope Task (Wilson et al., 2008; Huppert,
Johnson, & Nickson, 2000). Participants’ mean scores increased following treatment, with a
medium sized group effect. The researchers concluded that early intervention with this
population via group treatment could minimize everyday memory failures (Kinsella et al., 2009).
Bourgeois (2013) expanded upon Kinsella's et al. (2009) group intervention study with
activity-based training for individuals with MCI. The treatment emphasized the importance of
goal-oriented treatment targets and group training. This study examined eight participants with
MCI who completed a 10-week group treatment program for memory impairments. The
researcher taught multiple cognitive support strategies (i.e., written supports, organization,
routines, active observation, and verbal elaboration) and encouraged participants to use the
strategies that worked best for them. Bourgeois (2013) measured objective memory performance
using the Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005) pre- and post-training
and reported maintenance or decrease in scores following treatment. Strategy use, as measured
by the MMQ, increased following treatment. Participants reported using at least one strategy
(most frequently used: calendars, routines, visual cues, and written reminders), and seeing
improvement in the performance of everyday tasks that required memory skills. Long-term
maintenance of trained strategy use was not measured. It is unknown if EMA use maintained
7

following treatment or if maintenance would be more lasting if training focused exclusively on
EMAs. Teaching only external memory aids could allow for greater repetition of concepts and
more robust learning effects. In addition, group treatment could potentially be more personalized
to the individual's cognitive communication needs when training only one strategy.
Sohlberg and Mateer (1989) developed a formal training program consisting of teaching
EMAs in three phases (i.e., acquisition, application and adaptation) for individuals with
traumatic brain injury. Research has shown that individuals with TBI experience fewer everyday
memory failures when trained to use EMAs using this approach compared to supportive group
treatment (Schmitter-Edgecombe, Fahy, Whelan, & Long, 1995).
Few MCI treatment studies involve instruction in EMAs using a structured approach like
Sohlberg and Mateer’s three-phase training program (1989). Greenaway, Duncan, and Smith
(2012) instructed people with MCI to use calendars/planners through the Memory Support
System, a pocketsize calendar (two pages per day) and note taking system. The researchers
trained 20 dyads (individuals with MCI and their caregiver), for twelve, one-hour sessions across
six weeks, to use EMAs through the three-phase training program (Sohlberg & Mateer, 1989).
The MSS included three sections: 1) appointment, 2) “to do” items, and 3) journaling. The
researchers reported the trained participants significantly improved activities of daily living as
measured by the memory scale of The Everyday Cognition (Farias et al., 2008) following
intervention and 8-weeks later; however, these changes were not maintained at the six-month
follow up. The findings of this study suggest individuals with MCI can learn to use EMAs for up
to 8 weeks provided appropriate training, and the use of an explicit single strategy treatment of
sufficient training duration (Stott & Spector, 2011).

8

To better understand how to provide the most effective instruction in compensatory
memory strategies for people with MCI, researchers need to evaluate the type of training
program and EMA that is most likely to produce long lasting outcomes. To date, no treatment
programs for people with MCI have included Sohlberg and Mateer’s (1989) three-phase training
approach using a group model. The current study evaluated an intervention program that
incorporated individualized training within a group format. Specifically, the researchers
evaluated the effects of a structured group treatment intervention on functional EMA use,
cognitive abilities, and long-term maintenance of skills.
Research Questions
1. What is the effect of structured group treatment for individuals with probable MCI on
their functional use of external memory aids to compensate for memory impairments
compared to before treatment and do these changes maintain for six-weeks and 18months following intervention?
2. What is the effect of structured group treatment for individuals with probable MCI on
their cognitive skills post-treatment and do these changes maintain for six-weeks and 18months following intervention?
Methods
Participants
Individuals in the current study’s community based sample self-reported memory
impairments and completed activities of daily living independently. Seven females (ages 72 to 88
years) requested to be involved in the study and completed study consent procedures. The
participants lived independently at the same senior retirement apartment complex, spoke English
as their first language, and reported no prior learning or language impairments. The independent
9

retirement living complex is for individuals above the age of 62 who require no in-home medical
or functional assistance. Participants were distinguished from individuals with major
neurocognitive disorder in that according to self and staff report, they completed basic activities
of daily living independently (Petersen, 2004). Exclusion criteria also included a self-reported
history of psychiatric illness and a score greater than 25 on the MoCA. The researchers used the
MoCA as a descriptive measure to confirm the presence of mild memory impairment
representative of probable MCI. Six participants scored an overall mean of 23 (range = 21 to 25)
on the MoCA (which is within the range of MCI (21 to 25)) (Nasreddine et al., 2005) (Table
2.1). Only one potential participant was excluded from the study due to her MoCA score of 26.
The participants were randomly divided into two nearly equivalent groups of three people each
[Group 1: MoCA M(SD) score = 23.6/30 (1.5); Group 2: 23.3/30 (2.0)]. Group 1 participants
were older (M=82; SD=8.7) than Group 2 participants (M=74 years; SD=1.0).
Table 2.1. Participant Demographics.
Participant

Group

1
2
3
Mean (SD)

1
1
1

4
5
6
Mean (SD)

2
2
2

Age
(years)
88
72
86
82 (8.71)

Years of
Education
12
14
12
12.66 (1.55)

Vision
Screening
Pass
Pass
Pass

Hearing
Screening
Pass
Pass
Pass

MoCA
Score
24
25
22
23.66 (1.5)

75
75
74
74 (1)

12
14
14
13.33 (1.15)

Pass
Pass
Pass

Pass
Pass
Pass

24
25
21
23.33(2.0)

Materials
Screening. Participants’ self-reported medical history and ability to complete activities of
daily living were obtained through a structured interview of auditorily presented questions. The
examiner documented information obtained from the interview on a demographic form.
10

Questions regarding medical history inquired about medications specific to cognitive
functioning, psychiatric illness, stroke, neurological disorders, and language/learning
impairments. The participants were also asked questions related to functional independence. For
example the examiner asked, “what daily activities do you need assistance with and why?” The
researcher then restated the question specifically to gain information about cooking, cleaning,
bathing, and dressing. In addition, the director of the senior living facility was asked the same
questions regarding each participant to confirm independent completion of daily tasks.
Functional vision and hearing screenings were administered to assess impairments that may
possibly impact conversation of a small group. The participants’ hearing was assessed for
standard pure tone averages (i.e., 500 Hz, 1000 Hz, and 2000 Hz) at 25dB HL (within normal
hearing classifications) using a portable audiometer (American National Standards Institute,
2004; Lin, Thorpe, Gordon-Salant, & Ferrucci, 2011). Five participants passed the hearing
screen at 25dB HL and one participant passed at 30dB HL. This pass criterion was deemed
appropriate because of the testing environment noise level and mild hearing loss classification
that did not impact functional conversation (Huang & Tang, 2010). All of the participants passed
the vision screen. The vision screening consisted of a visual scanning task in which the
participant pointed to her name from foil names written in 18-point font on a piece of white
paper (five rows of four names each).
Dependent measures. The participants’ functional EMA use was evaluated with a
researcher-designed Role Play Activity in which a pre-recorded, 2-minute voicemail about an
upcoming event (e.g., doctor appointment) was played (Appendix A includes an example
transcript). To reduce practice effects, the researchers developed several voicemails following
the same format. The information within the voicemails (e.g., the type of appointment) were
11

altered each administration. The version of the voicemail was randomly administered to each
participant. The examiner told the participants they would hear a voicemail and be asked
questions immediately following the recording. The examiner told the participants they could use
any of the EMAs on the table (i.e., notepad, calendar or iPad) during the task. After the
voicemail played, the examiner asked seven wh-questions about facts from the recording. The
examiner documented live, using a scoring sheet, recall accuracy (i.e., accurate/inaccurate) and
type of EMA used (i.e., none, notepad, calendar, or iPad) for each question. The answers to the
wh-questions were scored as either correct (1 point) or incorrect (0 points). For example, if the
participant provided the incorrect date of the appointment no points were awarded for that
question. The scores ranged from 0 to 7, which was accurate responding to the seven whquestions. A second rater scored the video recordings of the assessment sessions using the
scoring sheet.
Participants’ perceived functional use of a variety of EMAs was measured with the
MMQ-Strategy subtest. Participants rated their use of 19 strategies as either all the time (4),
often (3), sometimes (2), rarely (1) or never (0). Higher scores represent greater frequency of
strategy use (maximum score = 76). The researchers used the Immediate-Recall and DelayedRecall subtests of the Arizona Battery for Communication Disorders of Dementia (ABCD;Bayles
& Tomoeda, 1993) as an additional measure of cognitive ability.
Treatment materials. The researchers trained three categories (i.e., calendar, timer, and
personal information) of EMAs. Within each category, the participants used three types of aids;
including a range of no-tech to high-tech aids (refer to Table 2.2). The researchers provided the
types of aids within each EMA category for participants to use and keep during treatment and
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home practice; however, the iPad versions of the EMAs were only used during assessment and
treatment sessions.
Table 2.2. Types of External Memory Aids.
Calendars
(Weeks 1 and 4)
iPad Calendar

Timers
(Weeks 2 and 5)
iPad Alarm and Stopwatch

Personal Information
(Weeks 3 and 6)
iPad Notes application

Paper Monthly

Stopwatch

Memory Wallet

Planner (weekly and monthly)

Hand Held: manual and
electronic clip-on

Planner (contacts,
passwords, and notes)
pages)

Design
The Duquesne University Institutional Review Board approved this study. The study
implemented an experimental pre/post group treatment design to evaluate the effects of training
EMAs during treatment group (Group 1) on participants’ functional EMA use and cognitive
skills in comparison to the delayed treatment group (Group 2). Group 1 and 2’s participants
completed individual pre-treatment assessments at the same time period to examine equivalence
of groups prior to intervention. Following the pre-treatment assessment sessions, participants in
Group 1 completed six weekly group treatment sessions and a single post-treatment assessment
session immediately following treatment. Participants in Group 2 did not receive treatment
immediately to serve as a control to compare individuals who did receive intervention (Group 1)
to individuals who did not (Group 2). Therefore, participants in Group 2 completed an additional
assessment (second pre-treatment session) during the same time period as Group 1 participant’s
post-treatment assessment sessions. Following the second pre-treatment session, participants in
Group 2 completed six weekly group treatment sessions, and a single post-treatment assessment
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session immediately following treatment. Participants in Group 1, during the same time period as
Group 2 participant’s post-treatment assessment sessions, completed a six-week follow up
assessment session, to examine retention of intervention skills. All participants completed an 18month follow-up assessment session after treatment concluded to examine long-term changes
(Table 2.3 shows the study schedule). Participants completed the sessions in a quiet room at the
senior retirement apartment complex. The sessions lasted approximately 90-minutes and were
video-recoded. In addition, half of the treatment sessions were transcribed for treatment fidelity
and scoring reliability purposes.
Table 2.3. Study Procedures.
Groups

Week 1

Weeks 2-7

Week 8

Weeks 9-15

Week 16

1.5 year

Group
One

Pretreatment
Assessment

Group
Treatment

Posttreatment
Assessment

No
Treatment

Six-week
Follow-up
Assessment

18-month
Follow-up
Assessment

Group
Two

Pretreatment
Assessment

No
Treatment

Second
Pre-treatment
Assessment

Group
Treatment

Posttreatment
Assessment

18-month
Follow-up
Assessment

Procedures
Pre-Treatment. During the individual pre-treatment assessment session, all participants
completed the screening measures (i.e., vision and hearing screenings, a medical history and
functional status interview guided by the demographic form, and the MoCA). If the participant
met the study criteria, the examiner administered the remaining assessment measures (i.e.,
ABCD Immediate –Recall, Role Play Activity, MMQ-Strategy, and ABCD-Delayed-Recall).
Treatment. Each participant completed six weekly group treatment sessions, during
which the examiner trained three categories of EMAs following a detailed training manual. As
shown in Table 2.2, two non-concurrent sessions were dedicated to each category of EMAs.
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Within each category, three EMA types (ranging from high-tech to low-tech) were taught to the
participants. During each treatment session, the examiner trained the EMAs in three-phases,
acquisition, application, and adaptation (Sohlberg & Mateer, 1989). The integration of the
three-phase training approach within the current group treatment is described below.
Introduction of the treatment approach. During the first session, the examiner provided the
participants with a schedule of the six-week treatment program. Next, the examiner described the
EMAs categories and types included in treatment.
Introduction of a new category of external aids. The introduction of a new category of
EMAs was the acquisition phase. The first category of EMAs was explained to the participants
using a handout (see Appendix B). The examiner discussed how to use each aid and appropriate
situations for using the aid. The participants also shared how they currently used any of the EMA
types and contributed ideas for situations that might benefit from the use of EMAs.
Functional practice. The next phase was the application phase, which involved various roleplay scenarios using the EMAs to promote functional use. For example, the examiner said, “If
your friend is having a surprise birthday party, how could you use this aid to remember the date,
time and type of party. Show me… ”. Group members were instructed to provide each other
feedback and brainstorm alternative approaches. During this phase for sessions 1 through 3,
participants used each type of EMA to complete the role-play scenarios. This provided
participants with exposure to all EMA types and multiple opportunities to practice within an
EMA category. During sessions 4 through 6, participants chose which type/types of EMAs they
wanted to use within the category to complete the role-play scenarios. Approximately five roleplay scenarios were completed during this phase of treatment resulting in repetitive practice.
Examples of calendar role play activities included scheduling appointments, planning dinners,
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and organizing rides for grandchildren. Timer role play activities involved timing items in an
oven, a workout routine, and remembering to get laundry. Finally, personal information
examples included emergency contact information, doctors’ names, and grandchildren clothing
sizes.
Explanation of home practice with new aids. The final phase was the adaptation phase,
which involved using the aid in a naturalistic environment. At the end of each session, the
researchers provided a home practice handout. The handout provided questions for participants
to reflect upon their experiences using the aid throughout the week. The homework promoted
generalization and worked toward establishing routine use of the EMA. All six participants
completed homework and shared examples of positive and negative functional EMA use.
Review of home practice activity. Following home practice, the participants started the next
session with group discussion. Guided by their home practice handout, the participants described
use of the EMA during the home practice activity and provided each other with suggestions. The
participants provided feedback to each other and indicated similarities and differences in their
experiences. The participants often used other participants’ ideas and altered their EMA use
based on the home practice discussion.
Post-Treatment. Both groups completed individual post-treatment assessments immediately
following treatment. During assessments the researchers administered the dependent measures
(i.e., Role Play Activity, MMQ-Strategy, MoCA, and ABCD-subtests).
Follow-Up. Participants in Group 1 completed an individual six-week follow-up session.
Participants in both groups completed an individual 18-month follow-up session. During both
follow-up assessment sessions, the researchers administered the dependent measures.
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Data Analysis and Reliability
The researchers compared between groups and within participant’s pre/post dependent
measure scores to examine the effect of treatment on participants’ functional EMA use and
cognitive skills. The data were analyzed using descriptive statistics and non-parametric statistics
to examine the effect of treatment on participant maintenance of functional EMA use and
cognitive skills. Due to the small sample size and unequal scores across groups, the researchers
conducted the Wilcoxon Signed-Rank Test and the Wilcoxon Rank-Sum Test. Participants’ pretreatment to post-treatment assessment scores and post-treatment to 18-month follow-up
assessment scores were compared to examine changes within participants over time using the
Wilcoxon signed-rank test. The researchers also compared post-treatment assessment scores of
Group 1 to pre-treatment assessment scores of Group 2 to examine treatment differences across
groups using the Wilcoxon rank-sum test. The first and second pre-treatment scores of
participants in Group 2 were averaged together to reduce testing error.
To examine treatment fidelity, two raters scored 20% of the treatment sessions. The raters
used a checklist (from the treatment procedure manual) to compare their scores with the
examiner’s scores of the treatment videos and transcriptions. Overall percent agreement was
calculated to be 87% (85 to 90%) documenting excellent inter-rater reliability.
To examine inter-rater reliability of the Role Play Activity, a second rater watched the
assessment sessions. The rater used the Role Play Activity scoring sheet to score the participant’s
recall accuracy and EMA use. After independent scoring, the rater and examiner compared
scoring sheets; 100% point-to-point agreement was obtained.
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Results
Functional External Memory Aid Use
Role play activity. As shown in Tables 2.4 and 2.5, the recall accuracy mean score
during pre-treatment for Group 1 was 3.33(SD=2.88) and Group 2 was 5.66(SD=1.52)
(maximum score=7.00). Following treatment, Group 1 increased their mean recall accuracy score
to 6.00(SD=0) and Group 2’s second pre-treatment mean maintained at 5.66(SD=1.25)).
Following treatment, Group 2’s mean score was 6.00(SD=1.73). Only Group 1 was assessed at
the six-week post-treatment. As shown in Table 2.4, Participant 1 and 2 increased their posttreatment Role Play Activity score of 6.00 to 7.00 and Participant 3 post-treatment score of 6.00
decreased to 3.50 during six-week follow-up assessment. During 18-month follow-up
assessment, Group 1’s mean score decreased from 5.83(SD=2.02) to 5.16 (SD=2.36) and Group
2’s mean score also decreased from 6.00(SD=1.73) to 4.83(SD=2.02). A Wilcoxon SignedRanks Test indicated that the post-test ranks were not statistically significantly higher than the
pre-test ranks N=5, T=2; p>0.05. A Wilcoxon Rank Sum Test indicated that the difference
between Group 1’s and Group 2’s summed ranks immediately following treatment of Group 1
was not statistically significant T=9, p>0.05.
In addition to recall accuracy, the Role Play Activity provided information about the
types of EMAs participants used. Only Participants 2, 5, and 6 used a notepad during the pretreatment assessment. During Group 2’s second pre-treatment Participant 6 maintained EMA use
and no other participants used an EMA. Following treatment, all participants used an EMA (five
participants used a notepad). Participant 4 began the assessment using the iPad and switched to
the notepad half way through the assessment.
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During six-week follow-up, Participants 1 and 2 continued to use the notepad. Participant
3 used the notepad halfway through the six-week follow-up task; the questions she answered
correctly were when the notepad was used. During 18-month follow-up assessment, 5 of the
participants used a notepad during the Role Play Activity (Participant 4 did not use an EMA). A
Wilcoxon Signed-Ranks Test revealed no statistically significantly difference between post-test
and follow-up ranks, N=4, p>0.05.
Table 2.4. Group 1's Role Play Activity Scores and EMA Type.
Pre-Treatment

Post-Treatment

Immediate Follow-Up

Long-Term Follow-Up

Recall (7)

EMA Use

Recall (7)

EMA Use

Recall (7)

EMA Use

Recall (7)

EMA Use

P1

5

0

6

1:Notepad

7

1:Notepad

6

1:Notepad

P2

5

1:Notepad

6

1:Notepad

7

1:Notepad

7

1:Notepad

P3

0

0

6

1:Notepad

3.5

2.5

1:Notepad

Mean

3.33

.33

6

1

5.83

5.16

1

½:Notepad
.83

Table 2.5. Group 2's Role Play Activity Scores and EMA Type.
Pre-Treatment

2nd Pre-Treatment

Post-Treatment

Long-Term Follow-Up

Recall (7)

EMA Use

Recall (7)

EMA Use

Recall (7)

EMA Use

Recall (7)

EMA Use

P4

4

0

6

0

4

3

0

P5

6

1:Notepad

4

0

7

2:iPad;
Notepad
1:Notepad

7

1:Notepad

P6

7

1:Notepad

7

1:Notepad

7

4.5

1:Notepad

Mean

5.66

.66

5.66

.33

6.00

4.83

.66

1:Notepad
1.33

MMQ-Strategy. Higher scores on the MMQ-Strategy subtest indicated greater
frequency of daily strategy use to compensate for memory impairments (maximum score=76).
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As shown in Tables 2.6 and 2.7, Group 1’s MMQ-Strategy pre-treatment mean score was
35.66(SD = 7.76) and Group 2’s mean score was a 38.00(SD = 6.92). Following treatment,
Group 1 increased their mean score to 39.66(SD = 4.04) and Group 2’s second pre-treatment
mean score was 39.00(SD = 5.19). Following treatment, Group 2 increased their mean score to
42.33(SD = 6.65). A Wilcoxon Signed-Ranks Test indicated that the post-test ranks were
statistically significantly different than the pre-test ranks N=6, T=1.5, p=0.03, α=0.025. A
Wilcoxon Rank Sum Test indicated no statistically significant difference between Group 1’s and
Group 2’s summed ranks immediately following treatment of Group 1 N=6, T=12, p>0.05.
During six-week follow-up assessment, Participants 1 and 2 decreased their MMQStrategy score and Participant 2 increased her score. Group 1’s six-week follow-up mean score
decreased from 40.66(SD=8.14) to 33.66(SD=7.63) during 18-month follow-up assessment.
Group 2’s post-treatment mean score slightly increased from 42.33(SD=6.65) to 43.00(SD=6.08)
during 18-month follow-up assessment. A Wilcoxon Signed-Ranks Test indicated that the 18month follow-up ranks were not statistically significantly different than the post-treatment ranks
N=6, T=9, p>0.05.
Table 2.6. Group 1's Total Dependent Measure Scores.
MMQ-Strategy

MoCA

ABCD-Immediate

ABCD-Delayed

Pre

Post

Im.F

Lt.F

Pre

Post

Im.F

Lt.F

Pre

Post

Im.F

Lt.F

Pre

Post

Im.F

Lt.F

P1

42

39

37

42

24

28

29

29

17

17

17

17

17

17

17

17

P2

27

36

35

27

25

28

28

25

14

16

17

15

15

14

15

15

P3

38

44

50

32

22

26

27

25

10

13

16

16

11

11

16

15

Mean

35.6

39.6

40.6

33.6

23.6

27.3

28.0

26.3

13.6

15.3

16.6

16.0

14.3

14.0

16.0

15.6
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Cognitive Skills
Montreal Cognitive Assessment. As show in Tables 2.6 and 2.7, Group 1’s pretreatment mean score was 23.66(SD = 1.52) and Group 2’s mean score was 23.33(SD = 2.08)
(maximum score=30). Following treatment, Group 1 increased their mean score from 23.66 to
27.33(SD = 1.15). Group 2’s second pre-treatment mean score was 24.33(SD =0.57). Following
treatment, Group 2 increased their mean score to 25.33(SD = 1.52). A Wilcoxon Signed-Ranks
Test indicated that the post-test ranks were statistically significantly different than the pre-test
ranks N=6, T=0, p=0.01, α=0.025. A Wilcoxon Rank Sum Test indicated that the difference
between Group 1’s and Group 2’s summed ranks immediately following treatment of Group 1
was not statistically significant N=6,T=6, p=0.05.
During six-week follow-up assessment, Participants 1 and 3 increased their MoCA score
by a point and Participant 2 maintained her score. During 18-month follow up assessment, Group
1’s mean MoCA score decreased from 28.00(SD=1.00) to 26.33(SD=2.30). Group 2’s mean
MoCA score decreased from 25.33(SD=1.52) to 23.66(SD=1.15). A Wilcoxon Signed-Ranks
Test indicated that the 18-month follow-up ranks were not statistically significantly different
than the post-treatment ranks N=6, T=13, p>0.05.
Table 2.7. Group 2's Total Dependent Measure Scores.
MMQ-Strategy

MoCA

ABCD-Immediate

ABCD-Delayed

Pre

Pre2

Post

Lt.F

Pre

Pre2

Post

Lt.F

Pre

Pre2

Post

Lt.F

Pre

Pre2

Post

Lt.F

P4

34

36

39

47

24

25

25

23

12

11

09

09

12

09

11

11

P5

46

45

50

46

25

24

27

25

12

15

15

13

11

13

13

13

P6

34

36

38

36

21

24

24

23

11

11

15

14

12

09

13

11

Mean

38.0

39.0

42.3

43.0

23.3

24.3

25.3

23.6

11.6

12.3

13.6

12.0

11.6

10.3

12.3

11.6
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ABCD-Subtests. As shown in Tables 2.6 and 2.7, Group 1’s mean score on the ABCDImmediate Recall subtest (maximum score= 17) at pre-treatment was 13.66(SD = 3.51) and
Group 2’s mean score was 11.66(SD =0.57). Following treatment Group 1’s mean score
increased to 15.33(SD = 2.08) and Group 2’s second pre-treatment score was 12.33(SD = 2.30).
Following treatment, Group 2’s mean increased to 13.00(SD = 3.46). During six-week follow-up
assessment, Participant 1 maintained the maximum score and Participants 2 and 3 increased their
scores. During 18-month follow-up assessment, Group 1’s mean score slightly decreased from
16.6(SD=.57) to 16(SD=1) and Group 2’s mean score decreased from 13(SD=3.46) to
12(SD=2.6). A Wilcoxon Signed-Ranks Test indicated that the post-test ranks were not
statistically significantly different than the pre-test ranks N=5, T=3, p>0.05. A Wilcoxon Rank
Sum Test indicated that the difference between Group 1’s and Group 2’s summed ranks
immediately following treatment of Group 1 was not statistically significant N=6, T=7, p>0.05.
A Wilcoxon Signed-Ranks Test revealed no statistically significant difference between the posttest and follow-up ranks N=4, p>0.05.
As shown in Tables 2.6 and 2.7, Group 1’s mean ABCD-Delayed Recall (maximum
score = 17) pre-treatment assessment score was 14.33(SD = 3.05) and Group 2’s mean score
was 11.66(0.57). Following treatment, Group 1 maintained their pre-treatment mean score of
14.00(SD = 3.00). Group 2’s second mean pre-treatment scores decreased from 11.66(SD
=0.57) to 10.33(SD = 2.30). Following treatment, Group 2’s mean score was a 12.33(SD =
1.15). During six-week follow-up assessment, Participant 1 maintained the maximum score
and participants 2 and 3 increased their ABCD-Delayed Recall assessment scores. During 18month follow-up assessment, Group 1’s mean score slightly decreased from 16(SD=1) to
15.6(SD=1.1) and Group 2’s mean also decreased from 12.33(SD=1.15) to 11.66(SD=1.15)
22

on the ABCD-Delayed Recall subtest. A Wilcoxon Signed-Ranks Test revealed no
statistically significantly difference between pre-test to post-test ranks and post-test to followup ranks N=4, p>0.05. A Wilcoxon Rank Sum Test indicated that the difference between
Group 1’s and Group 2’s summed ranks immediately following treatment of Group 1 was
statistically significant N=6, T=6, p=0.05.
Discussion
The current study examined the effects of group treatment on enhancing EMA use and
cognitive abilities of individuals within the community with probable MCI.
Functional EMA Use
Role play activity. Overall, the results related to the primary outcome measure
suggested that group EMA treatment increased the participants’ functional EMA use. The Role
Play Activity depicts a common cognitive communication activity of daily living, which is
critical, because individuals with MCI often report having difficulties with complex activities of
daily living (Constantiniduo et al., 2012). Although the Wilcoxon tests revealed non-significant
effects, N=5, T=2; p>0.05, an overall increase in EMA use and score on the Role Play Activity
post-treatment likely reflects a positive change in the participants’ ability to participate in
activities of daily living affected by their cognitive communication impairments. A significant
effect was not revealed on the Wilcoxon Signed-Ranks Test because the test could not be
completed at the .05 alpha level, due to the participant’s maintained strategy use performance on
the Role Play Activity. Although all participants did not increase performance, maintenance of
skills is important because of the possible progressive nature of the impairments.
Most participants used the notepad for the Role Play Activity during the post-treatment
assessment. The participants may have selected the notepad because of their past experiences
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with its effectiveness or their level of comfort in using a notepad as compared to the other
EMAs. Future research should examine the participants' rationale for selecting specific EMAs to
help determine which EMAs clinicians might recommend during treatment.
Only one participant attempted to use the notes feature on the iPad following treatment.
However, she was unable to use the iPad with the efficiency required to successfully complete
the Role Play Activity and therefore received a lower score. Importantly, the participant realized
she was not collecting the information appropriately and switched to using a notepad. This
example suggests that failures during home practice and discussion within the group may have
allowed the participants to self-assess their use of EMAs and consider the importance of
switching strategies mid-task. Researchers have found that individuals are most likely to use an
EMA outside of treatment if they have encountered periods of failed strategy use during
intervention (Sohlberg & Mateer, 2001). Therefore, clinicians should continue to integrate
multiple EMAs into treatments and encourage discussion of failures and successes with each
type of EMA.
MMQ-Strategy. In addition to the Role Play Activity, researchers examined
participants’ perceptions of functional EMA use through the MMQ-Strategy subtest. The
statistically significant difference of post-treatment to pre-treatment MMQ-Strategy ranks (N=6,
T=1.5, p=0.03, α=0.025), as indicated by the Wilcoxon Signed-Ranks Test, support the positive
impact of treatment on participants’ understanding and reported daily EMA use. Previous MCI
strategy treatments also found positive changes in the participants' MMQ-Strategy subtest scores
(Bourgeois, 2013; Kinsella et al., 2009). Although the current study's treatment only focused on
one memory strategy (EMAs) and had a smaller number of participants compared to the other
studies, the participants still increased their self-reported use of strategies post intervention. Prior
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to intervention, the pre-treatments group means were not equal and had relatively large standard
deviations [Group 1: MMQ-Strategy M(SD) score = 35.66 (7.8); Group 2: 39.66 (4.0)]. These
differences could possibly be the rationale for the non-statistically significant differences
indicated by the Wilcoxon Rank Sum Test. Future research should include multiple measures to
examine pre-treatment strategy knowledge and possibly better understand differences across
participants.
While the gains within the current study were minimal, given the progressive nature of
the participants’ diagnoses and the similar findings from previous studies, the improvements in
EMA use during a structured activity (i.e., Role Play Activity) and reported EMA use (i.e.,
MMQ-Strategy) during functional activities highlight the potential benefits of group EMA
intervention for individuals with probable MCI.
Cognitive Skills
MoCA. Although the primary aim of the intervention was to provide instruction in the
use of compensatory strategies, statistically significant rank differences between post-treatment
and pre-treatment on the MoCA suggests participants’ cognitive skills were indirectly affected.
That is, participants demonstrated a slight increase in or maintenance of cognitive abilities during
post-treatment assessments. These data should be interpreted with caution, however, because of
the small sample size, relatively small change demonstrated, and non-significant differences
between Group 1 and Group 2’s summed ranks immediately following treatment of Group 1.
Previous research by Bourgeois (2013) indicated a slight decrease in MoCA scores postintervention, despite improvements in memory strategy use. Bourgeois' intervention (2013)
focused on a variety of memory strategies (e.g., organization, verbal elaboration, and active
observation) throughout the treatment sessions. However, the current study trained a single
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strategy (i.e., EMAs). The preliminary results reported in Bourgeois' (2013) study suggests that
the intensity and repetitive design of the current single strategy study may be a possible
explanation for the increase in cognitive skills noted.
ABCD-Subtest. The statistically significant difference between Group 1’s and 2’s
summed ranks immediately following treatment of Group 1 for the ABCD-Delayed Recall
subtest, as indicated by the Wilcoxon Rank Sum Test, further supports the indirect relationship
between EMA treatment and change in delayed recall skills. Improved scores on both the MoCA
and ABCD assessments of delayed recall provide support for a possible indirect relationship
between single-strategy EMA intervention and positive effects on the participants’ delayed recall
skills. Future research should further explore the relationship between EMA intervention and
delayed recall skills for individuals with probable MCI.
Although MCI can be a progressive condition, other studies that have examined cognitive
interventions have identified improvements in cognitive abilities (e.g., Li et al., 2011). The
intensity and repetition throughout the current study's single-strategy, EMA, treatment approach
could have had an effect on the participants’ cognitive skills, compared to studies of multiple
strategy approaches.
Retention of Skills
Participants in Group 1 were assessed six-weeks post-intervention and all participants
were assessed approximately 18 months later to analyze retention of skills after a period without
treatment. The differences between post-treatment and follow-up assessment scores were
inconsistent and not statistically significant across all dependent measures. These data of
retention of functional EMA use are similar to the results found by Kinsella et al. (2009). Both
the current study and the Kinsella et al. (2009) study found inconsistent participant scores;
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however a majority of participants reported decreased strategy use during follow-up assessments.
Therefore, when some participants are not receiving treatment they perceive a decrease in daily
strategy use. Individuals would probably benefit from on-going treatment or continued booster
sessions once intervention is complete. The current study was the first to examine long-term
(greater than one year) EMA use following intervention. Willis et al. (2006) examined long-term
effects five-years following cognitive training; however, the researchers provided booster
training. The researchers found an increase in participants’ reasoning and speed of processing
when provided booster training (Willis et al., 2006).
Limitations
Although the current study findings provided support for group EMA treatment for a
sample of individuals with probable MCI, the study included several limitations. The study
sample size was small, although appropriate for an exploratory study, and limits the conclusions
that can be drawn. Additionally, all the participants were women and lived in the same apartment
complex. Gender and the group size may affect the dynamics and interactions within groups and
should be investigated in future studies with familiar and unfamiliar group members.
Some of the findings relate to participants’ self-perception of memory impairments and
EMA use. Although the MMQ is a validated assessment tool, the limitations of self-reported data
are still present. In the future, informants who live with the participant could also rate
participants’ use of EMAs to provide another measure for comparison.
Due to the exploratory community based nature of this study, the researchers conducted
limited cognitive testing without alternative forms (MoCA, ABCD-subtests) and did not seek a
physician’s diagnosis to include participants. Data on the rate of progression will allow
researchers to best measure the relationship between the treatment and participants’ cognitive
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skills. Overall the current knowledge on MCI progression is inconclusive (Petersen et al., 2014).
If more information was known on the rate of progression, researchers could more appropriately
examine the importance of maintenance of skills. The current study’s data analysis deleted cases
that the participants maintained performance, resulting in a minimum p-value of .0625. Future
research should consider incorporating a single-participant study design. Due to the unknown
rate of progression and inconsistent participant performance, a single-participant design may
better account for individual differences and maintenance of skills. In addition, future research
needs to continue to assess participants for longer follow-up periods and define more
appropriately the exclusion criteria to reduce variability and better identify progression (Petersen
et al., 2014).
Conclusions
This preliminary study employed a small community sample to describe effects of an
innovative evidence-based, group treatment for EMA use in people with probable MCI. Positive
findings suggest that individuals with probable MCI can learn to use EMAs and they report that
EMAs positively affect their daily life by improving cognitive communication skills.
Additionally, group EMA treatment resulted in small gains in objective cognitive skills for some
participants. Future research should investigate the effect of various types of EMA treatments on
use of aids in daily life and possible changes in cognitive skills.
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CHAPTER THREE: EXTERNAL MEMORY AID PREFERENCES OF INDIVIDUALS
WITH MILD MEMORY IMPAIRMENTS
Note to Reader
Portions of this chapter have been previously published in Seminars in Speech and
Language, 2018, 39(3): 211-222, and have been reproduced with permission from Thieme
Medical Publishers.
Introduction
As individuals age, cognitive changes become more common and may interfere with
everyday activities. Older adults frequently notice changes in their memory, especially shortterm impairments (e.g., walking into the bedroom and forgetting why they went in the bedroom)
and delayed-intention impairments (e.g., planning on going to a specific store and then forgetting
to do so when they are out) (Cohen-Mansfield et al., 2005). These impairments may be related to
age associated cognitive changes; however, another potential etiology of these impairments may
arise from a progressive neurodegenerative pathology.
The Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V;
American Psychiatric Association, 2013), classifies neurocognitive disorder across a continuum
from mild to major impairments and uses etiologies to determine subtypes (e.g., neurocognitive
disorder due to Alzheimer’s disease). To distinguish between mild and major severities, the
cognitive and functional skills of an individual are described. Individuals with mild
neurocognitive disorder have impairments in one or more cognitive domains and complete
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activities of daily living independently; however, they often require the use of compensatory
strategies to complete tasks successfully (American Psychiatric Association, 2013).
Compensatory strategies are beneficial for individuals with cognitive impairments
because, either, the demands placed on one’s impaired abilities are limited, or the preserved
abilities of an individual are reinforced through appropriate task modification (Sohlberg &
Turkstra, 2011). Compensatory strategies for memory can be divided into two major categories:
internal and external aids. Internal memory aids, such as mental rehearsing and mnemonics, rely
on one’s memory ability and help reorganize the way one stores and retrieves information.
Internal memory aids are often difficult for individuals with progressive impairments because of
the reliance on memory skills and increased demands on cognitive processing (Stott & Spector,
2011). External memory aids (EMAs), however, reduce cognitive demands by capitalizing on
one’s remaining strengths and incorporating environmental cues (Lanzi, Burshnic, & Bourgeois,
2017). For example, if a person is consistently misplacing their hearing aids, a container can be
placed on a nightstand with a note stating, “I put my hearing aids here before bed.” The written
note capitalizes on preserved reading abilities and the location of the container is an
environmental cue. EMAs, such as written notes, are evidence-based approaches that promote
functional activities in naturalistic settings for individuals with mild neurocognitive disorder
(Sohlberg & Turkstra, 2011).
Researchers suggest that individuals with mild memory impairments can learn how to use
EMAs when they are provided appropriate training (Bourgeois, 1993). Using such EMA
strategies in everyday situations often improves topic maintenance in conversation, increases
independent completion of activities, and decreases problematic behaviors (Bourgeois, Burgio,
Schulz, Beach, & Palmer, 1997; Hoerster L, Hickey, & Bourgeois, 2001; Kinsella et al., 2009).
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Additionally, maintaining independence has been associated with improved overall
quality of life (Hopper et al., 2013). Although EMAs are well researched and generate positive
treatment effects, a considerable proportion of individuals provided with supports never use them
following intervention (Cohen-Mansfield et al., 2005; Gitlin, Schemm, Landsberg, & Burgh,
1996; Scherer, 2005). The adoption and continued use of an EMA strategy may depend on how
the strategy is developed and trained. An individual’s needs, daily life, and environment should
be considered in both the design and training phase of a strategy to promote long-term EMA
maintenance. Integrating a person-centered approach will best support clinicians in evaluating
the whole person and environment (Lanzi et al., 2017; Scherer, 2005). In using a person-centered
approach, the focus of care shifts from the individual’s impairment to his or her remaining
strengths. Examining an individual’s strengths includes not only cognition, but also emotional
and psychosocial abilities (Epp, 2003). When designing a compensatory strategy, the primary
goal is for the individual to integrate the approach into daily life and for the approach to meet the
person’s individual needs. Therefore, psychosocial factors, such as family, culture, and gender,
will affect the structure of the strategy. For example, if a female is the family cook she may
benefit from a cookbook adapted for memory and executive functioning needs to support
successful completion of a favorite recipe. Each individual has unique needs, abilities,
expectations, and past experiences that may affect the design and eventual reaction to
compensatory strategies. Therefore, it is the responsibility of the skilled professional to analyze
and provide multiple feature choices of the EMAs during the strategy development phase for
individuals with neurocognitive disorders.
Including skilled professionals throughout the continuum of compensatory strategy
services is not a novel concept. The International Classification of Functioning, Disability, and
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Health (ICF), developed by the World Health Organization considers external strategies to be
environmental factors (World Health Organization, 2001). Examining EMAs within the ICF
framework is critical because environmental factors can directly affect body functions, activities,
and participation (Scherer, Hart, Kirsch, & Schulthesis, 2005). An individual’s participation in
everyday environments, such as public areas and work sites, depends on accommodations,
assistance, and accessible forms of information. Without these resources, an individual with
disabilities loose self-identified meaning in societal or desired social roles. Additionally, most
everyday environments include barriers for individuals with cognitive disabilities (e.g.,
insufficient maps available at a shopping mall and inconsistent aisle layouts at grocery stores).
Therefore, professionals need to carefully consider one's everyday environment to ensure the
EMA will be used within the community setting. Incorporating a person-centered approach into
the development phase of strategies will best assist professionals in supporting the individual
with a disability. One method of implementing a person-centered approach in the strategy
development phase is by examining individual preferences and attitudes toward EMAs (Brown,
Hux, Hey, & Murphy, 2017). Although there is a critical need to examine individual preferences,
limited research exists to guide professionals.
Researchers have attempted to investigate potential factors that influence EMA use and
provide information regarding commonly used strategies. For example, Wilson (1991) gathered
information from 43 individuals who had experienced a severe head injury resulting in severe
memory-impairments following rehabilitation. The researcher reported that the number of
strategies used by an individual related to the level of independence he or she reported. In
addition, the most commonly used strategies included notebooks, calendars, lists, and mental
retracing of events. Wilson and Watson (1996) expanded upon these data to identify specific
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personal factors related to positive and negative strategies used by individuals seven years post
brain injury. The following factors were found to predict use of six or more memory aids: age,
severity of memory impairment, absence of additional cognitive deficits, and premorbid memory
strategy use. To better define the predictive factors and examine commonly used supports, Evans
and colleagues (2003) surveyed 94 individuals with memory-impairments post brain-injury. The
researchers reported 79.5% of the most commonly used aids to support memory-impairments
were non-electronic. Of the 44 different aids reported to be used by participants, the top four
included: a wall calendar (n=68), a notebook (n=60), a list (n=59), and an appointment diary
(n=51). The most commonly used electronic EMAs included an alarm clock (n=38) and watch
with date or timer (n=17). The researchers also reported additional personal predictive factors
and analyzed the direct relationship between the number of strategies used and level of
independence. The results of the reviewed studies highlight the importance of examining
personal factors and individual differences that impact strategy use.
Although the results from the previously discussed studies indicate that non-electronic
EMAs are used most often, researchers continue to investigate individual preferences across the
range of technology-based EMAs. For example, Brown and colleagues (2017) employed a
mixed-methods design to evaluate the cognitive support preferences of eight participants with
acquired brain injuries. The researchers reported inconsistent strategy use by participants: three
participants used low-tech supports and four participants used high-tech supports. Qualitative
analysis of transcripts revealed four subthemes regarding desirable external cognitive strategies:
1) having access to pop-up reminders; 2) system portability, convenience, and access; 3) task
prioritization features; and 4) having adequate space for note recording. When presented with a
variety of strategies, five of eight participants chose high-technology strategies as their most
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preferred type. This is especially important, because technology use has likely evolved
throughout the years between the reviewed publications. These findings provide important
insights when developing strategies for individuals while incorporating a person-centered
approach.
Similarly, Cohen and colleagues (2005) administered a questionnaire to 100
community-dwelling seniors to examine user characteristics, user requirements, and operational
requirements regarding electronic EMAs. The researchers reported 58% of participants answered
“yes” they would use an electronic device. The best predictors of participants’ willingness to
learn how to use an electronic EMA were familiarity with machines and statements about the
importance of different features of the electronic EMAs. Participants’ most reported everyday
memory impairments were forgetting birthdays and missing medications. The majority of
participants (92%) used a calendar and phone book frequently and 73% of participants preferred
the aid to be small, or hand held. In addition, participants reported previous physical problems
associated with electronic EMAs (e.g., hard to operate due to the size of the buttons). The
authors suggested that more than one method should be offered to individuals and limitations of
the aid for each individual need to be considered during the strategy development phase. In
addition, this study provided initial evidence of the electronic EMA preferences of older adults.
However, more research is needed to investigate individual preferences for older adults across all
types of EMAs.
In summary, the reviewed studies highlight the importance of using a holistic, personcentered approach when developing compensatory memory strategies for people with
neurocognitive disorders. Due to the limited frequency of strategy maintenance following
intervention, researchers must continue to explore individual preferences to enhance strategy use
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(Scherer et al., 2005). The majority of participants in the previous research studies had
neurocognitive disorders from acquired brain injury and involved a focus on electronic EMAs.
The aims of the current study were to explore EMA strategy preferences of older adults with
mild memory impairments/possible mild neurocognitive disorder from a degenerative
neurological disease who received intervention exploring multiple types of EMAs (ranging from
no-tech to high-tech). Unlike the previous studies that involved data collection prior to
intervention, in the current study individual preferences were evaluated during and following
intervention employing a mixed-methods design.
Research Questions
1. Which types of EMAs do older adults with mild memory impairments prefer following a
group-based intervention?
2. How do older adults with mild memory impairments describe their experiences
exploring, selecting, and implementing EMAs for completion of functional activities
during a group-based intervention?
Methods
The researchers obtained qualitative data from a group treatment study for individuals
with mild memory impairments/possible mild neurocognitive disorder; the quantitative data is
presented in an associated paper (Lanzi, 2016). The group treatment study included a total of six
participants (three participants in both Treatment Group 1 and Treatment Group 2 [Delayed
Treatment Group]). To examine the preferences of individuals following treatment, the
researchers qualitatively explored the data from a post-treatment preference questionnaire
administered individually to each of the six participants. Additionally, to examine participant
experiences during intervention, the researchers conducted a thematic analysis of the transcripts
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of Treatment Group 1’s intervention sessions following conclusion of the study. A
transcendental phenomenological approach (Moustakas, 1994) was used to qualitatively evaluate
the transcripts. This approach allowed the researchers to explore meanings and perceptions of
individuals regarding a specific situation (Brown et al., 2017). In addition, this approach was
selected due to the importance of understanding the shared experiences of group members during
an intervention training several EMAs and the approach was used in similar research with
individuals with acquired brain injuries (Brown et al., 2017).
Participants
As described in the associated research (Lanzi, 2016), six female participants completed
the group EMA intervention after consenting to participate using Duquesne University
Institutional Review Board's approved forms. All participants passed the functional vision and
hearing screenings and lived by themselves in a senior retirement apartment complex.
Participants completed activities of daily living independently, however, they all reported
changes in cognition (specifically, memory). In addition, all participants scored between 21 and
25 on the Montreal Cognitive Assessment (Nasreddine et al., 2005). Participants were divided
randomly into two groups of three individuals each: Treatment Group 1 and Treatment Group 2
(Delayed Treatment Group). The mean (SD) age of Group 1 participants was 82 (8.7) years and
Group 2 participants was 75 (1.0) years.
Procedures
Group intervention. The group intervention study (Lanzi, 2016) consisted of six
consecutive intervention sessions. During the intervention, the examiner presented three
categories of EMAs (i.e., calendars, timers, and personal information). The examiner dedicated
two intervention sessions to explore each category. The three EMA categories included three
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types of aids ranging from no to high technology approaches (as described below). The examiner
provided each type of EMA for the participants to use during the intervention sessions. In
addition, the participants could keep all of the aids, except the high-technology version (i.e.,
iPad), to use during home practice and following intervention. Although the participants were
not given the iPad to use on their own, the examiner encouraged the participants to use their own
cell phone or computer during home practice.
Calendars. The two types of no-tech calendars were in paper formats. The first type was
a calendar in the form of a planner with a weekly and monthly view. The planner was 6x4 inches
and included every month and week of the year. The second version of a calendar was a monthly
version that hung on the wall, spanning 12x10 inches. The high-technology version of the
calendar was accessed on an iPad. The electronic calendar provided monthly, weekly and daily
views.
Timers. Low-tech timer options included an electronic stopwatch and handheld timers (a
digital clip-on and manual dial version). The timer was used as a reminder to complete tasks at a
certain time or to help one allot time to better manage their schedule. The high-tech version of
the timer/alarm was accessed on the iPad.
Personal information. Two no-tech options to record personal information included: 1) a
12-slot double-sided business card memory wallet provided to each participant; 2) the notes
section in the back of their planner. The notes section was divided into 10 pages (i.e., 3 pages for
addresses, 3 pages for passwords and 4 pages were blank with lines). The high-tech version to
record personal information was accessed on the Notes application of the iPad.
The examiner used the Sohlberg and Mateer (1989) three-step EMA training program
(i.e., acquisition, application, and adaptation) throughout the intervention. During each treatment
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session, the participants explored the features of each type of aid within the category (acquisition
phase), completed role-play activities using the aids (application phase), and followed
instructions regarding home-practice (adaptation phase). Following each session, the participants
led the next session with discussion regarding home-practice using the aids previously trained.
Each treatment session lasted approximately 90-minutes and was video recorded.
Preference questionnaire. The post-treatment questionnaire was used to obtain
information about participants’ preferences and rationales for using, or not using, the types of
EMAs within each category following intervention. The semi-structured questionnaire consisted
of six open-ended questions and was administered by an examiner individually with each of the
six participants (both Group 1 and Group 2) during a single 30-minute session following the
conclusion of intervention. Each EMA category was discussed with two questions. The
interviewer asked the participants (1) which type of aid she preferred within the category (i.e.,
calendar, timer, and personal information) and (2) to explain her rationale for this selection. Each
individual session was video recorded and the examiner took notes during the sessions.
Intervention video transcripts. To examine participants’ experiences exploring,
selecting, and implementing EMAs during intervention, the research assistants transcribed the
six video files representing Treatment Group 1’s intervention sessions. The research assistants
were trained on verbalization verbatim transcription (including emotional expressions, e.g.,
laughing). Following completion of training procedures, three research assistants were each
assigned to review two of the six video files. Additionally, each research assistant conducted
transcription reliability on two additional files; they calculated an overall mean agreement score
of 94%, ranging from 92-97% for each transcript.
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Data Analysis and Reliability
Preference questionnaire analysis. The researchers conducted a qualitative descriptive
data analysis of the post-treatment preference questionnaire to examine the six participants'
preferences following intervention. In addition to the notes, recorded by the interviewer, a
research assistant transcribed the participant's answers from the video recording. The transcribers
used the interview answer sheet to report which EMA the participant preferred and the rationale
for the selection. The interviewer and research assistant compared answer transcriptions and
reported 100% point-to-point agreement reliability.
Intervention transcripts analysis. To examine participants' experiences and attitudes
while using the EMAs during intervention, the researchers conducted a thematic analysis of the
six transcripts from Treatment Group 1’s intervention sessions. To analyze the six treatment
session transcriptions, the researchers used the transcendental approach to phenomenology with
triangulation (Creswell, 2013; Moustakas, 1994).The qualitative analysis approach was similar to
that employed by previous researchers (Brown et al., 2017) who examined EMA preferences for
individuals with acquired brain injury.
The members of the research team jointly analyzed a transcript to identify specific
statements revealing information about the participants’ experience, attitudes, and opinions
regarding the trained EMAs. Then the researchers developed narrower meaning units within the
transcripts to later be used to represent themes present across the three participants within
Treatment Group 1. Next, two members of the research team independently analyzed all
subsequent transcripts and developed initial themes within the data using a coding sheet. The
researchers then discussed emerging themes and developed a label and definition for each theme.
The labels and definitions for each theme were added to a revised coding sheet. The research
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members used the final coding sheet to reanalyze the transcripts independently and also
identified key statements within the transcript that best represented the themes. Following the
reanalysis, the researchers met to discuss any discrepancies and calculated an overall mean
agreement score of 96%, ranging from 95-97% for each transcript.
Results
Preferences Following Intervention
To determine individual preferences regarding the types (high technology, low
technology, and no technology) of EMAs within each category (i.e., calendars, timers, and
personal information), the researchers reported qualitative data obtained from the post-treatment
preference questionnaire. Most participants had a clear preference for one type of EMA.
In the calendar category, two participants preferred the paper daily view because the
large amount of space allowed for entering the most amount of information compared to the
other types. Four participants preferred the paper monthly type, because of the size and ability to
plan by seeing the entire month in one view. In the timer category, all six participants preferred
the clip-on timer due to its simple-to-use features and portability. To record personal
information, two participants preferred the memory wallet due to its small size. In contrast, two
participants preferred the planner, because of its portability and sufficient space to write details.
Finally, the remaining two participants chose both the memory wallet and planner. The
participants stated the rationale for choosing two types was due to the types of task and setting
(e.g., emergency medical information would be kept in the memory wallet and detailed
information about their doctors would be kept in the planner). No participants preferred the hightechnology versions in any category trained during intervention.
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Experiences During Intervention
In addition to examining participants' preferences following intervention, the researchers
analyzed experiences during intervention obtained from qualitative analysis of transcripts
representing Treatment Group 1’s intervention sessions. Qualitative analysis of the six treatment
transcripts revealed five major themes: 1) positive reactions to EMA use; 2) negative reactions to
EMA use; 3) adoption and modification of EMAs; 4) memory ability awareness; and 5) attitudes
about technology. Although all participants had statements representative of each theme, there
was variability based on unique needs and person-based situations. The variability was explored
through the identification of sub-themes. Illustrative participant quotes are italicized and appear
within parenthesis in the following sections.
Positive reactions to EMA treatment. Participants’ shared information revealed three
subthemes regarding positive reaction to the treatment: (i) successful use of EMAs; (ii)
helpfulness of EMAs; and (iii) sense of accomplishment. Each participant reported a positive
reaction to using the EMAs in and outside of treatment sessions. For example, participants
described successful use of the aids during role-play activities during treatment sessions.
Participants reported more success using the aid during home practice following the second
intervention session that was dedicated to training the EMA category. Participants often reported
that the EMAs helped them in a situation during a home practice activity (e.g., “the personal
information was helpful to me, where to put it and where to carry it”). Additionally, they often
described feeling accomplished when using the EMAs outside of treatment (e.g., “just give me
his name and phone number and there it was! In my wallet thing”).
Negative reactions to EMA treatment. Although the participants discussed many
positive reactions to the EMA treatment, there were some negative feelings about the aids. The
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analysis of the transcripts revealed three subthemes regarding negative reactions to EMAs: (i)
hearing and vision limitations; (ii) not useful for the individual; and (iii) hesitation towards using
the EMA. Hearing and vision limitations, due to natural aging, resulted in participants having
negative reactions to the types of EMAs (e.g., “Well, if I could see it better, I would like it very
much”). Throughout the sessions, there were also occasions for which the participants
commented that they had no use for the EMA (e.g., “I don’t use the timer”, “I probably could
but I don’t”. “My nose is a good timer if I’m cooking”). Participants were often hesitant during
the first session to use new EMAs, but became more comfortable during the second session to
explore the types of aids within the category.
Adoption and modification of EMA. Participants’ discussion of adopting and
modifying the EMAs to fit their everyday needs revealed three subthemes: (i) personalization of
the EMA; (ii) applying the EMA daily; and (iii) organization. Participants described the
importance of establishing daily, routine use of EMAs (e.g., “the thing that has helped me the
most is training myself to look at the calendar, to use the calendar regularly, on the daily
basis”). The participants commented that the aid provided structure in their daily routine (e.g. “It
forces me to be a little more organized, and to look ahead, and also to keep current. That I think
was one of my biggest problems”). Participants often adapted what they learned in treatment and
personalized the EMAs (e.g., color coding doctors’ appointments in their calendar and adding
symbols to important calendar events) to accommodate their unique needs.
Memory ability awareness. Participants’ discussions during intervention resulted in
three subthemes regarding memory ability awareness: (i) recognition of memory ability; (ii)
remembering to use the EMA; and (iii) acceptance of memory. Participants frequently
commented on what they had remembered or forgotten throughout the week and how the EMAs
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were helpful when used daily (e.g., “I try to write things down on the calendar. My problem is I
forget to look at it.”). Progression through the weekly sessions demonstrated a transition from
recognizing their memory challenges to learning how to cope with them, and eventually
accepting their memory abilities towards the end of intervention.
Attitudes about technology. Participants expressed (i) frustration, (ii) needing more
practice and (iii) excitement when using EMAs involving technology. A lack of familiarity and
problem-solving skills resulted in the participants feeling frustrated (e.g., “it gave me trouble
because I was trying to set an alarm, and I hit that button and it went to T2 (a location outside of
the alarm)”). Participants often expressed wanting more practice with technology. Following
success with technology, the participants frequently expressed excitement. These positive and
exciting feelings increased throughout the intervention sessions.
Discussion
The use of an EMA is an evidence-based approach that has been shown to support
individuals with neurocognitive disorder by enhancing performance completing everyday tasks.
The current study aimed to add to the limited literature base on the EMA preferences of older
adults with mild memory impairments/possible mild neurocognitive disorder following
intervention. Additionally, the researchers aimed to explore participants' experiences during a
group-based intervention that trained several EMAs. Although it is important to examine the
functional effects following EMA training, individual preferences must be explored to help
researchers and clinicians appropriately develop compensatory strategy-based interventions.
Therefore, the current study’s findings intend to support a person-centered approach throughout
the continuum of EMA interventions.
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Preferences Following Intervention
The results from the post-treatment questionnaire highlight the importance of supporting
individual differences because most participants did not prefer the same type of aid within each
category. Additionally, the results support the importance of considering an individual's sensory
needs and environment during the EMA development phase.
Individual differences. Unlike previous strategy interventions, the group intervention
(Lanzi, 2016) trained the participants on several types of EMAs within one category. In the
calendar category, the participants preferred either the no-tech monthly or planner version.
Although the participants’ demographic characteristics were similar, differences existed amongst
their preferences to record and view information within the calendar. Similar to previous
research findings (Brown et al., 2017) participants considered the space to record information
when determining the preferred type of EMA. Some individuals preferred an aid that had enough
space to record a large amount of daily information and other participants preferred to have
enough space to view the entire week. Regardless of the preferred EMA, space to record
information was an important consideration.
Differences also existed within the participant's preferred method to record personal
information. In fact, two participants chose to use the memory wallet and the planner, and stated
their selection depended on the type of information that needed to be recorded. This finding
supports the practice of providing individuals with multiple types within one EMA category.
Until the field gains a better understanding of how individual preferences impact use, clinicians
and researchers should allow the individual to choose the type of EMA to ensure maximum
success for a variety of everyday tasks. Clinicians can also provide guidance based on the
predicted progression of impairments.
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Considering sensory impairments. The majority of participants differed on the types of
strategies preferred; however, all six participants preferred the clip-on version within the timer
category. The participants stated their rationale for choosing this type of aid was due to the
convenience, size, and volume level. In comparing the clip-on version to the other types within
the timer category, the distinguishing features are the ability to wear this aid paired with simple
access components. The participants reported that the other types were difficult to hear and were
unreliable. Additionally, the participants’ changes in hearing impacted their ability to hear the
iPad and manual timer when it was out of reaching distance. Therefore, when choosing and
designing EMAs it is critical to consider changes in sensory abilities and easy to use operation
features to decrease the cognitive and sensory burden when utilizing the strategy.
Independent living. A unique feature of the group intervention study (Lanzi, 2016) was
that the participants lived by themselves at a senior retirement apartment complex. The
participants in similar group intervention studies (Bourgeois, 2013; Kinsella et al., 2009) also
completed activities of daily living independently, but did not live alone. In addition, a proxy
who either lived or was closely associated with the individual also participated in the study. This
contrast with previous studies is important because the participants in the current study were
solely responsible for completing activities of daily living independently. Therefore, the aids
needed to be both portable and support a variety of activities. Previous researchers have also
identified the importance of utilizing small portable aids, regardless of the type of cognitive
impairment experienced by an individual (Brown et al., 2017; Cohen-Mansfield et al., 2005).
Participants in the current study stated that the EMA needed to be useful in a variety of
environments (e.g., home, doctor’s appointment, and shopping mall). One possible reason for
this finding may be due to the fact that the participants of the current study were solely
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responsible for completing their activities of daily living independently. Previous researchers
suggest that the number of strategies used by individuals is related to their level of independence
(Wilson, 1991). This finding is also similar to the discussion by Scherer and colleagues (2005)
who emphasized the importance of considering one’s environment when designing strategies.
Current strategy development practices do not support continued strategy use within one's
environment. Therefore, a large majority of participants never maintain use of strategies
following intervention (Scherer, 2005). If researchers and clinicians intend for the trained
strategy to be used within community settings, then continued research is needed to develop
appropriate methods to investigate the effect of personalization on EMA use.
Experiences During Intervention
The current study not only adds to the limited literature on individual EMA preferences,
but also provides insight into the participants' experiences during the intervention where they
were provided with hands-on trials with the aids. The five major themes that emerged primarily
relate to the preference findings from the post-treatment questionnaire. In addition, the
qualitative data analysis provides more information as to why participants did not prefer the
high-tech versions of the aids and describes the benefits of a group-based training.
Individual differences. The theme of positive reactions to EMA treatment highlights the
importance of training these types of strategies to individuals with probable mild neurocognitive
disorder. However, the themes of negative reactions to EMA treatment and adoption and
modification of EMAs depict the need to personalize the strategies for each individual. For
example, one participant discussed how the manual timer is not useful for her because she uses
the timer on the microwave. Also, the specific subtheme of personalization of the EMA emerged.
The participants made several comments related to specific ways she adapts the aid based on her
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unique needs. One participant, for example, used a check mark to indicate completion of an
event within her calendar. These findings further support introducing an individual to several
types of EMAs and encouraging specific features to enhance strategy personalization.
Considering sensory impairments. Although individuals had negative reactions to the
EMA treatment several comments focused on normal aging sensory impairments. For example,
one participant stated, “Well, if I could see it better, I would like it very much.” Previous
researchers who investigated preferences of older adults also reported several physical
limitations, such as, accessing the aids (Cohen-Mansfield et al., 2005). The negative reactions to
the strategies regarding sensory impairments are critical for researchers and clinicians to address
when designing strategies. Several strategies can be adjusted to accommodate normal aging
sensory impairments; however, more research is needed documenting these accommodations.
Attitudes about technology. The findings from the post-treatment questionnaire reported
that the participants did not prefer the high-tech versions within any EMA category. This
preference is not uncommon, as previous researchers (Evans et al., 2003) reported 79.5% of
participants with brain injuries preferred low-tech types of aids. The qualitative analysis of the
intervention transcripts revealed a theme entitled attitudes about technology. The participants
discussed becoming frustrated when they were unsure how to operate the electronic EMA. They
also discussed that they did not have enough practice using the high-tech versions of the aid.
This could possibly be due to the limitation of not providing the participants with the high-tech
versions during home practice. Interestingly, the participants reported being excited when they
operated the high-tech version successfully.
Previous researchers have also found that most older adults are interested in learning how
to use electronic EMAs, however, their level of familiarity with the device often predicts
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successful use (Cohen-Mansfield et al., 2005). The associated group intervention study (Lanzi,
2016) did not examine how the individuals operated high-tech devices prior to the intervention.
Therefore, when the examiner introduced the high-tech version of the aid most of the
intervention time was spent on basic operation features. Future research should examine a
participant's familiarity with a device and skills prior to intervention.
Another important consideration is the possible effect of a participant's age on preferred
(electronic or non-electronic) EMAs. The mean age of the participants in the current study was
82 years old (Range= 72-88 years). Previous research related to preferences of individuals with
acquired brain injury has reported that the participants often preferred electronic EMAs (when
presented with several types) and have a high comfort level using electronic devices (Brown et
al., 2017; Bourgeois, 2003). However, the mean age of the participants in the Hart et al (2004)
study was 31.5 years (Range=17 to 70 years) and in the Brown et al (2017) study was 26 years
(Range=19 to 39 years). Therefore, the reason for the differences in preferences may relate to the
age of the individuals rather than etiology. Future research should explore methods for
supporting individuals who may be less familiar with technology and consider ways to best
support individuals who are more familiar with technology (Wallace, Graham, & Saraceno,
2013).
Group-Based intervention. Unlike the post-treatment preference questionnaire data
analysis, the qualitative analysis of the intervention transcripts examined the participants as a
group. Previous preference research has only conducted data from individuals rather than in a
group setting. Therefore, themes emerged regarding the impact of individuals participating in a
group intervention. Specifically, the participants discussed how they would adapt an aid based
upon another group member’s suggestion. The participants also made several statements related
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to memory ability awareness. Statements from the participants discussed an initial recognition of
their memory ability and this could possibly be due to the support that working in a group
naturally provides. Future research should possibly examine the impact of individual versus
group training delivery on EMA preferences.
Limitations
Although the presented study supports further research examining individual strategy
preference, several factors limit the interpretation of the results. The study reported the
preferences of only six participants following intervention and three participants during
intervention. In addition, the participants represented a homogeneous group with limited
representations across demographic factors (e.g., race and sex). All participants were females
and resided in the same senior apartment complex. It is possible that gender could affect
individual preferences and similar living experiences could enhance comfort levels during the
intervention impacting one’s overall experience.
The researchers of associated group intervention study (Lanzi, 2016) also did not require
participants to have a formal diagnosis of mild neurocognitive disorder by a medical physician;
rather the inclusion criteria incorporated the DSM-V criteria (American Psychiatric Association,
2013). Although the inclusion criteria were described and included a community-based sample
of individuals with mild memory impairments/possible mild neurocognitive disorder, the
preferred support characteristics may not generalize to individuals with an official diagnosis of
mild neurocognitive disorder made by a physician. Future research should consider if an official
diagnosis may impact one’s experience and preferences towards strategy characteristic as
opposed to a community-based sample.
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Conclusions
Clinicians and researchers often use person-centered evidence-based approaches to
implement EMAs; however, these approaches are rarely used to choose and design such
strategies prior to intervention. Findings from the presented study support the need to implement
person-centered approaches into the design phase of EMAs because individuals have unique
needs, comfort levels, and experiences that impact overall use of the strategies. Current practice
highlights a disconnect between intervention and direct application to functional daily activities;
therefore, individuals with neurocognitive disorder often do not maintain strategy use following
intervention (Scherer, 2005). The current study's findings aim to assist clinicians and researchers
with implementing a person-centered approach throughout the continuum of strategy
development, choice, modification, implementation, and generalization for older adults with mild
memory impairments/ possible mild neurocognitive disorders.
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CHAPTER FOUR: STRUCTURED EXTERNAL MEMORY AID TREATMENT FOR
MILD COGNITIVE IMPAIRMENT
Note to Reader
Portions of this chapter are in press in American Journal of Speech-Language Pathology
and have been reproduced with permission from Origin Editorial.
Introduction
As individuals age, cognitive changes become evident and may interfere with everyday
tasks. Although changes are expected during normal aging, some individuals experience
cognitive impairments that decrease their speed and efficiency to complete complex activities of
daily living. In America, approximately 20% of older adults are living with symptoms of Mild
Cognitive Impairment (MCI; Roberts et al., 2012). Individuals with MCI can complete activities
of daily living independently; however, because their memory impairments exceed those of
normal aging they may rely on compensatory strategies to complete daily tasks (DSM-V,
American Psychiatric Association, 2013; Petersen, 2004).
Since 2013, the DSM-V has included MCI within the neurocognitive disorder (NCD)
diagnostic category. Mild and major NCD classifications are based on severity of cognitive
impairments and completion of activities of daily living (American Psychiatric Association,
2013). Although individuals within the mild NCD (mNCD) classification rely on compensatory
strategies to maintain independence while completing daily tasks, limited measures are available
that measure one’s strategy use in everyday tasks. In addition, individuals with mNCD are at
greater risk than normal aging peers for their impairments progressing to the major classification
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(Csukly et al., 2016). However, the rate of progression and presentation of symptoms vary by
individual and the tools used to measure these changes. Most assessments of cognitive skills,
such as the Montreal Cognitive Assessment (MoCA; Nasredine et al., 2005) and the Repeatable
Battery for the Assessment of Neuropsychological Status (RBANS; Randolph, Tierney, Mohr, &
Chase, 1998), measure performance on cognitive tasks that do not reflect everyday tasks. For
example, on the MoCA, to measure attention, individuals listen to a list of letters and respond
when a specific letter is stated. To date, there is not a functional performance measure that
examines one's daily use of compensatory strategies to support their cognitive challenges. It is
important to know what compensatory strategies might be effective early in the progression of
cognitive symptoms, such that, individuals can be encouraged or trained to use them more
consistently over time and modify them to maximize effectiveness.
Compensatory strategies are commonly taught to individuals with cognitive impairments
because they reduce the burden of the impaired processes by providing alternative access routes
to stored information needed to complete tasks (Lanzi, Burshnic, & Bourgeois, 2017). Many
types of compensatory strategies exist; calendars, timers, weekly planners, and memory
notebooks are examples of external memory aids (EMAs) that are commonly used to enhance
daily task performance (Bourgeois, 2013; Lanzi et al., 2017; Sohlberg & Mateer, 2001). Most of
the compensatory strategy intervention studies have used a group format for teaching strategy
use (Bourgeois, 2013; Greenaway, Duncan, & Smith, 2012; Kinsella et al., 2009). Although
these studies provide evidence that individuals with mNCD can learn to use strategies, the
participants rarely maintain skills following intervention. Poor maintenance could possibly be
due to the lack of treatment emphasis on using preferred strategies and/or the measures used to
examine strategy use and functional behavior.
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For example, Greenaway and colleagues (2012) examined the effectiveness of training a
researcher-developed Memory Support System, as an EMA, through a randomized control trial of
40 individuals with mNCD. The Memory Support System consisted of a pocketsize calendar and
note taking system and was divided into three sections: (1) appointments, (2) “to do” items, and
(3) journaling. Intervention was delivered to individuals with MCI and their caregiver and
included 12, 1-hr sessions across three weeks. The researchers measured improvements in
activities of daily living using an informant-based memory scale: The Measurement of Everyday
Cognition (Farias et al., 2008). Participants increased activities of daily living following
intervention and 8 weeks later. However, improvements were not maintained 6-months post
intervention. In addition, the researchers measured adherence to the Memory Support System
(e.g., a point was scored if participants brought in the system). Participants reported increased
adherence immediately following intervention and 8 weeks later. These improvements were not
maintained 6-months post intervention. The adherence measure developed by the researchers
provided insight into the participant’s actual use of the trained strategy, which is important to
document treatment effects. However, the researchers failed to examine the effects of using the
strategy to enhance performance of everyday activities. Rather the researchers used an
informant-based tool to document the participants’ functional behavior. To better understand the
functional effects of compensatory treatments, researchers need to include measures that
simulate everyday tasks and examine strategy use.
Kinsella and colleagues (2009) developed a group treatment using a problem-solving
approach for memory impairments. In five treatment sessions, 52 individuals with MCI learned
about several strategies: external and internal memory aids, strategies for organizational and
attention skills, general coping skills, and the multifactorial construct of memory. The large
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number of strategies taught provided limited opportunities for participants to tailor the strategies
to their unique needs. Therefore, the focus of the intervention was on exposure to strategies
rather than use of preferred strategy types. To measure prospective memory, the researchers used
the Reminder Task and Envelope Task (Huppert, Johnson, & Nickson, 2000; Wilson et al., 2008).
A significant medium-size group effect was reported on the prospective memory tasks at both 2
weeks’ and 4 months’ follow-up assessments. The prospective memory measures used in the
study were performance-based and reflective of everyday tasks. Therefore, the results obtained
from the measures provided insight into the participants' functional behavior. However, the
measures did not examine the participants' strategy use within the everyday tasks. The
researchers administered the Multifactorial Metamemory Questionnaire to measure self-reported
memory strategy use (Troyer & Rich, 2002). The participants’ self-report of strategy use
improved 2-weeks following intervention, however, the improvements were no longer
statistically significant 4-months later. It is possible that the exposure to multiple memory
strategies, both internal and external, could have limited participants’ experience with a single
strategy that they might have adopted for daily use. Thus, we should investigate interventions
that prompt participants to tailor EMAs to meet their own daily needs and residual strengths. In
addition, the researchers discussed the limitations of using self-report measures; specifically, that
many self-report tools are confounded by subjective beliefs of memory and negative stereotypes
about age-related memory changes (Kinsella et al., 2009). Therefore, studies that use functional
performance-based measures to examine strategy use to document treatment effects are needed.
Lanzi, Wallace, and Bourgeois (2018a) examined the effects of teaching three categories
of EMAs (calendars, timers, and personal information) to six individuals with possible MCI in a
group format for six weeks. The researchers taught the EMAs using Sohlberg and Mateer’s
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(1989) three-step training program, in which they (1) explored several examples of EMAs within
each category, (2) role-played using the EMAs in everyday situations, and then (3) used the aids
in their home environment. The researchers encouraged the participants to tailor the strategies to
their individual needs and select their preferred EMAs in hopes that they would continue to use
them beyond the intervention period. The researchers developed the Role Play Activity
Assessment to document strategy use in tasks representative of activities of daily living.
Following intervention, participants demonstrated an overall increase in EMA use on the Role
Play Activity Assessment. Participants also reported statistically significant differences from preto post-treatment on the MMQ-Strategy, confirming the positive impact of treatment on selfreported functional strategy use. In addition, the researchers assessed the participants in Group 1
six-weeks following intervention and most individuals maintained strategy use on the Role Play
Activity Assessment. Eighteen months following intervention, however, only some individuals
maintained their skills; an overall mean decrease on the Role Play Activity Assessment and MMQ
scores were reported. Although the researchers reported an overall mean decrease, only one
participant’s Role Play Activity Assessment score deviated by more than one point. Thus, this
study provides evidence for using a roleplay-based measure to examine participants’ strategy use
in everyday tasks.
Unlike similar studies, Lanzi et al. (2018a) limited the number of EMAs taught and
encouraged participants to choose their preferred strategies throughout intervention. In a followup study, Lanzi, Wallace, and Bourgeois (2018b) examined the EMA experiences and
preferences of the participants during and following intervention. The researchers analyzed the
participants’ experience using EMAs during intervention from transcripts of video-recorded
treatment sessions. Analysis revealed 5 major themes: (1) positive reactions to EMA use; (2)
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negative reactions to EMA use; (3) adoption and modification of EMAs; (4) memory ability
awareness; and, (5) attitudes about technology. The researchers elicited participants’ EMA
preferences following intervention from a post-treatment preference questionnaire. Results
revealed unique preferences amongst individuals within each EMA category. These results
highlight the unique differences of participants’ EMA use and preferences across all three
categories taught and the importance of considering personal factors when designing EMAs.
In summary, evidence for the effectiveness of teaching the use of EMAs as a
compensatory strategy-based memory intervention is accumulating. The reviewed literature
highlights the need to design interventions that encourage participants to tailor EMAs to their
own needs, spared strengths, and personal preferences. Additionally, researchers need to
continue to explore the use of roleplay-based measures to document functional behavior and
strategy use. Thus, the purpose of the current study was to explore the effects of a structured
external memory aid treatment on the participants’ strategy use during the Roleplay Assessment
representative of several functional everyday tasks.
Research Questions
1. What is the effect of a structured external memory aid treatment for individuals with
possible mNCD on their use of external memory aids to compensate for memory
impairments?
2. To what extent does improved functional external memory aid use due to structured
treatment for individuals with possible mNCD maintain following intervention?
3. What is the effect of a structured external memory aid treatment for individuals with
possible mNCD on their self-reported memory skills?
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Methods
Participants
The participants in the current study represented a community-based sample of older
adults with possible mNCD (according to the DSM-V criteria); evidence of cognitive decline
from a previous level of performance (i.e., individuals self-reported mild memory impairments
and documented mild memory impairments on an objective cognitive measure), independent
completion of activities of daily living, and cognitive decline is not due to delirium or another
disorder (American Psychiatric Association, 2013). Approximately 25 older adults from a senior
community center in St. Petersburg, Florida met with the researchers and completed initial
recruitment procedures. After explaining the study and conducting screening procedures, the
researchers determined that six individuals met inclusion criteria. Participants’ MoCA score
(Nassredine, et al., 2005) confirmed the presence of self-reported memory loss in the range of
mNCD (Peterson, 2004); participants scored within the range of 18-25 (mean score=21; refer to
Table 4.1). Exclusion criteria included: self-reported history of depression or psychiatric illness
that resulted in hospitalization within the last two years, history of learning or language
impairments, history of stroke or brain injury, and non-English speaker. The six female
participants' ages ranged from 64-89 years old. All participants passed a functional hearing,
vision, and communication screening (Bourgeois, Dijkstra, Burgio, & Allen-Burge, 2001) and
completed informed consent procedures (using the University of South Florida institutional
review forms). As shown in Table 4.1, participants were randomly assigned to one of three dyads
(composed of 2 participants).
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Table 4.1. Participant Demographics.
Dyad

Participant

Age (years)

Years of Education

MoCA Scores

1

P1

77

16

20

1

P2

78

12

22

Mean

77.5

14

21

2

P3

71

16

21

2

P4

77

16

25

Mean

74

16

23

3

P5

89

16

20

3

P6

64

16

18

Mean

76.5

16

19

76

15.3

21

Overall Mean
Measures and Materials

Screening measures. Participants completed a demographic form to provide selfreported medical history and information regarding activities of daily living. The researcher
assessed sensory impairments using the Functional Hearing, Vision, and Communication
Screening Measure (FunctHVC; Bourgeois et al., 2001). During the administration of the
FunctHVC, the researcher observed each participant during a conversation and scored the
sensory areas (i.e., hearing, vision, and communication) on a scale of intact to severely impaired.
Dependent measures. The primary dependent measure was the Roleplay Assessment.
Each participant could score a maximum of 14 points on the Roleplay Assessment, representing
successful use of EMAs to complete three everyday tasks (refer to Appendix C). At the start of
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the assessment, the participant was told she could use any of the EMAs on the table (i.e.,
notepad, calendar or iPad) to help complete the three tasks.
Task one required the participant to remind the researcher to complete an activity (e.g.,
return a phone call) in two minutes. One point was marked on the scoring sheet if the participant
used one of the EMAs on the table, such as setting a timer. A score of 0 was marked if the
participant did not do anything with the EMAs on the table. An additional point was marked on
the scoring sheet if the participant reminded the researcher of the task in two minutes.
Task two was a voicemail retrieval task in which the participant heard a pre-recorded 40second voicemail about an upcoming event (e.g., doctor appointment). Prior to playing the
voicemail, the researcher informed the participant that she would be asked questions
immediately following the recording. The researcher asked seven wh-questions about facts from
the recording (e.g., What is the doctor’s name?) and used the scoring sheet to record recall
accuracy (accurate/inaccurate; possible scores: 0-7) and strategy use during the task (one point
was marked on the scoring sheet if an EMA was used). The maximum score for the voicemail
section was eight: indicating accurate responses to the seven wh-questions and use of a strategy.
Task three examined each participant's calendar use. Prior to the assessment, each
participant was asked to bring her personal calendar to the next session. During task three, the
researcher asked the participant to see her calendar (one point was awarded if calendar was
brought to session). The researcher also asked the participant to show three documented events
within the last two weeks. One point was scored for each event documented (maximum of three
points).
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To reduce the test-retest effects on repeated administrations of the Roleplay Assessment,
multiple versions of the task prompts were made. The structure of the three tasks did not change,
rather the content (e.g., doctors appointment vs. birthday party) within the tasks differed.
To assess the participants' self-reported memory skills and use of external memory
aids/strategies across three dimensions (i.e., ability, strategy, and contentment) the researchers
administered the Multifactorial Memory Questionnaire (MMQ; Troyer & Rich, 2002). The
MMQ is composed of 57 questions that are independently answered using a five-point Likert
scale (“all of the time” to “never”). The researchers of the current study modified the MMQ for
normal age-related sensory changes by increasing the font size, spacing, and page orientation of
the questionnaire.
Treatment materials. The intervention stimuli consisted of three categories of EMAs
(calendar, timer, and personal information). Within each category, EMA types ranged from notech to high-tech aids. The researchers provided the aids for participants to use and keep during
and following treatment. In addition, the researchers encouraged participants to bring in their
own EMAs within each category (if used).
Design and Procedures
The study implemented a multiple baseline design across subjects within dyads to
examine the participants’ use of EMAs to compensate for memory impairments. The
experimental sessions consisted of three phases: baseline phase, treatment phase, and
maintenance phase. The participants completed assessments individually; however, they received
treatment sessions in dyads to provide a group dynamic during intervention. The researchers also
employed a pre-post experimental design to examine the participants’ self-report of metamemory
skills following treatment using the MMQ.
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Pre-Treatment assessment. During the pre-treatment assessment session, the
researchers administered the screening measures (i.e., interview guided by the demographic
form, MoCA, and FunctVHC). All participants scored within normal limits on the FunctVHC.
After participants met criteria for study participation, the researchers administered the modified
version of the MMQ.
Baseline phase. Following the pre-treatment assessment session, all six participants
began baseline data collection. At the start of each baseline session the Roleplay Assessment was
administered individually to the participants. When stability in baseline data was observed (i.e.,
absence of improving trend, minimum variability, and generally low level across a minimum of
three sessions) by visual inspection of the graphed Roleplay Assessment scores, treatment began
for dyad 1 and the other two dyads remained in the baseline phase. During each session within
the baseline phase, the participants continued to complete the Roleplay Assessment. Due to the
multiple baseline design, each dyad’s baseline phase was increasingly longer than the previous
dyad’s (dyad 1= 3 baseline phase sessions; dyad 2= 5 baseline phase sessions; dyad 3=7 baseline
phase sessions).
Treatment phase. Following the administration of the Roleplay Assessment, treatment
sessions began in dyads. Each dyad completed four weekly sessions lasting approximately onehour within the treatment phase. Treatment was continued until a treatment effect for dyad 1 was
observed (i.e., positive change in level and minimal variability). Treatment sessions then began
with the next dyad whose baseline data was observed as low and stable (dyad 2). This procedure
was repeated until all 3 dyads completed the intervention sessions. To examine the treatment
effect at the start of treatment sessions 2-4, the researcher administered the Roleplay Assessment
individually to the participants.
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During the treatment sessions, the researcher followed a treatment protocol and taught
three categories of EMAs (i.e., timers, calendars and personal information). Each weekly session
was dedicated to one EMA category and within each category several types of aids were
discussed (refer to Table 4.2 for the treatment schedule). For example, within the personal
information category the researcher discussed a small notepad, a memory wallet, and a dry erase
board. Similarly to Lanzi et al. (2018a), the EMAs were taught in three-phases: acquisition,
application, and adaptation (Sohlberg & Mateer, 1989). The following section describes the
integration of the three-phases into the weekly treatment sessions within the current study.
Table 4.2. Treatment Schedule.
Treatment
Session

Week 1

Week 2

Week 3

Week 4

EMA Category

Calendar

Timer

Personal
Information

Review

EMA Training
Phases

1. Overview of
Treatment
2. Acquisition
3. Application
4. Adaptation

1. Discussion
of Home
Practice
2. Acquisition
3. Application
4. Adaptation

1. Discussion of
Home Practice
2. Acquisition
3. Application
4. Adaptation

1. Discussion
of Home
Practice
2. Review of
Weeks 1-3

During treatment session one, the researcher explained the overview of the treatment and
provided rationale for meeting in dyads (e.g., to share ideas of how to modify the EMAs). Then,
the researcher described how three categories of EMAs would be trained throughout the sessions
and explained how the participants are encouraged to try multiple types within each EMA
category and share ideas throughout the sessions.
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Next, the EMA category for the week was introduced during the acquisition phase (refer
to Appendix D). During this phase, the participants explored multiple types of EMAs within each
category. To enhance exploration, the participants and researcher discussed how to use different
EMA types and what situations would be appropriate and inappropriate for using the aid. For
example when discussing the monthly paper calendar, the participants described the benefit of
having opportunities to plan and look ahead but also discussed the difficulty of being unable to
travel easily with it due to the size. Each participant shared their previous or lack of experiences
using the types of aids within each category during the acquisition phase.
Following the discussion of the EMA types, the participants engaged in the application
phase to promote hands-on functional practice with the strategies. This phase involved several
simulated scenarios (approximately 3) using the different types of EMAs. For example the
researcher stated, “Show me how you would use the calendar to document the information from
this birthday invitation.” The participants were encouraged to complete the tasks with each EMA
type to facilitate a discussion on the pros and cons of each different strategy. The dyad format
facilitated discussion between participants on successful/unsuccessful scenarios and possible
personal modifications to enhance EMA use in the home environment. One participant, for
example, placed sticky-notes on her calendar when she needed to bring something with her to
later place it on the door as a reminder.
To facilitate functional EMA use outside of treatment the researcher introduced the
adaptation phase. During this phase, the participants were encouraged to use the trained EMAs
within their natural environment. For example, at the end of the session the researchers reviewed
a home practice handout with the participants. The handout asked the participants to use the
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EMAs and reflect upon their experiences throughout the week. All of the participants completed
the home practice activities throughout the intervention.
At the start of the following session, the participants discussed their home practice
experiences with the previous week’s EMA category. The participants provided each other with
suggestions and shared examples of positive and negative experiences using the EMAs to
complete everyday tasks. In addition, the participants discussed how they tailored the EMAs to
meet their own unique needs, incorporated the EMA into their daily routine, and provided
rationale for specific preferences amongst the types of strategies.
Maintenance phase. Following the treatment phase, dyads 1 and 2 completed monthly
maintenance phase sessions to examine the retention of strategy use. During the maintenance
phase the participants completed the Roleplay Assessment independently.
Post-treatment assessment. To examine the changes in self-report of metamemory skills
following intervention the participants completed the MMQ immediately following the
conclusion of the treatment phase sessions.
Reliability
Inter-Rater reliability. To examine reliability of the dependent measure a second rater
was trained by the researcher to record data on the Roleplay Assessments while watching the
session video recordings to a rate of 80% agreement with the researcher. Then the rater scored
20% the assessments independently. Inter-rater reliability was calculated by dividing the total
number of both raters’ Roleplay Assessment score in agreement by the total number of raters’
agreements and disagreements; 92% (range = 90%-94%) point-to-point agreement was obtained.
Fidelity. To examine treatment fidelity, a student independently scored 20% of the
treatment sessions. The rater used a checklist (from the treatment procedure manual) while
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watching the treatment videos to score fidelity of the intervention. The rater used the checklist to
document how successfully the researcher followed the treatment protocol during the
intervention sessions Overall the rater reported 92% researcher adherence to the treatment
protocol (range = 87-95%).
Results
Functional Use of EMAs
As can be seen through visual inspection of Figure 4.1, all participants demonstrated a
treatment effect, from generally low, stable scores in baseline to an immediate increase and
positive trend in the scores during treatment with no overlapping data between phases. In
baseline, there is limited variability across all participants’ data. The overall level of baseline is
different for each participant, reflecting EMA use prior to intervention for some participants.
However, the level of the data for each participant within the dyad is similar.
As each dyad began treatment a large positive change in level of the data was present,
indicating a treatment effect. To further support this conclusion, the researchers analyzed the
baseline phases of the remaining dyads. As the treatment for each preceding dyad began, the
subsequent dyads’ baseline data remained stable. Therefore, the change in the level of data is
concluded to be due to treatment effects rather than extraneous variables or a practice effect.
To further evaluate the treatment effects, the researchers conducted non-overlapping
indices: Tau U=1.0. The researchers also ran a multilevel regression model to estimate effect
sizes, restricted maximum likelihood estimation, and Kenward-Roger adjusted degrees of
freedom and standard errors using SAS 9.4. This approach has been shown to lead to valid
average effect size inferences (Ferron et al., 2009). In addition, this approach provides valid
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individual effect size inferences (Ferron, Farmer, & Owens, 2010) in the context of multiplebaseline studies with as few as four participants.
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Session

Figure 4.1. The score on the Roleplay Assessment across baseline, treatment, and maintenance
sessions for each of the three dyads.
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The researchers examined the average treatment effect (i.e., fixed effects) across dyads
and the variability of this estimated effect between cases (i.e., random effects) within dyads
using a two-level model. The data within Tables 4.3 and 4.4 can be compared to the visual
analysis of the graphs to further confirm the researchers' conclusions. The values in Table 4.3
represent the across case and time average number of functional EMAs used during baseline
(i.e., 4.00) and the across case average shift in the number of functional EMAs that occurred with
treatment (i.e., 7.03), which indicates during treatment the across case average number of
functional EMA’s is 11.03. The standard errors and confidence intervention are also presented in
Table 4.3 for each average estimate.
Table 4.3. Fixed Effects: Average Treatment Effect Across Dyads.

The values in Table 4.4 are the empirical Bayes (EB) estimates of the baseline level and
treatment effect for each participant. The treatment effects ranged from an increase of 5.26
functional EMA’s used by Participant 3 to an increase of 9.81 functional EMA’s used by
Participant 1. These individual effects were obtained by adding the random effect for the dyad
and participant to the fixed effect. The obtained values can be compared to the averages for
further analysis for each individual parameter estimate.
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Table 4.4. Random Effects (empirical Bayes): Variability of Estimated Treatment Effect
Between Participants.
Participant

Baseline Level

Shift in Level

Participant 1

3.12

9.81

Participant 2

2.86

7.68

Participant 3

6.53

5.26

Participant 4

6.47

6.71

Participant 5

2.20

5.93

Participant 6

2.80

9.31

Maintenance
As seen in Figure 4.1, the participants who received monthly follow-up sessions
maintained functional strategy use following intervention on the Roleplay Assessment.
Overall, the data in the maintenance phase across all four participants overlaps the data
collected in the treatment phase. Each participant retained EMA use, but for different increments
of time. Participant 1 and 4 maintained strategy use for one-month, Participant 3 maintained
strategy use for two-months, and Participant 4 maintained strategy use for three-months.
Self-Perceived Strategy Use
Researchers examined participants’ self-perceived memory skills by administering the
MMQ (refer to Table 4.5). The participants’ mean scores on the MMQ-Contentment and MMQAbility decreased slightly from pre to post treatment (MMQ-Contentment=43.0 to 42.8; MMQAbility=41.6 to 40.3). These changes were not statistically different for either subtest. However,
participants’ self-perceived use of strategies on the MMQ-Strategy subtest increased following
treatment as indicated by a large increase in mean scores (pre-treatment mean=34.5; post75

treatment mean=43.5). This change was statistically significant (t=0.01, p<.05).
Table 4.5. MMQ Scores and Pre-Post Sub-Scale Comparisons.
Pt. #

Contentment Contentment

Ability

Ability

Strategy Use

Strategy Use

Pre-Tx

Post-Tx

Pre-Tx

Post-Tx

Pre-Tx

Post-Tx

Pt. 1

25

37

34

38

31

39

Pt. 2

55

52

53

58

41

43

Pt. 3

49

46

44

42

35

47

Pt. 4

52

30

47

36

38

42

Pt. 5

57

56

55

49

19

37

Pt. 6

20

36

17

19

43

53

Mean

43.0

42.8

41.6

40.3

34.5

43.5*

Note. *p < 0.05
Discussion
The current study used a multiple baseline single subject design to evaluate the effects of
a structured group EMA treatment on (1) functional strategy use during a role-play assessment,
(2) retention of strategy use and (3) self-perceived memory skills.
Functional Strategy Use
Following intervention, a treatment effect was observed as indicated by a large positive
change in level of functional strategy use on each individual’s graph. The empirical Bayes
estimates further confirm the positive increase in strategy use across all participants. Therefore,
individuals with possible mild NCD can learn to use EMAs when provided structured group
instruction. This finding is similar to previous studies with individuals with MCI (Bourgeois,
2013; Greenaway et al., 2012; Kinsella et al., 2009).
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Similar to Lanzi and colleagues (2018a) the researchers used a measure that consists of
roleplay-based activities to document treatment effects. The Roleplay Assessment in the current
study depicts several functional situations. Therefore, an increase in performance is likely to
reflect positive changes in one’s ability to complete everyday cognitive communication tasks.
Thus, this study provides evidence for using a functional measure to examine treatment impact
on everyday skills.
These findings are similar to previous research examining the effect of cognitive
rehabilitation on everyday skills using performance-based functional measures. Specifically,
Schmitter-Edgecombe and Dyck (2014) measured changes in everyday abilities through
assessments that examined functional skills (i.e., medication management and bill paying). They
also reported positive changes on such performance-based tasks following intervention. These
findings suggest a possible increase in everyday performance of daily tasks; however, it is
unclear how these measures translate to functional skills. A unique component of the Roleplay
Assessment used in the current study is the tasks within the measure are performance and
adherence based. After exploring the individual scores within each task section, only one
participant actively used a calendar during the baseline phase. Following treatment, all six
participants had and used a calendar to document weekly events. This finding, reveals that the
participants used the taught strategy in everyday life. Future research should explore additional
methods of measuring strategy use in daily tasks.
The researchers of the current study not only expanded upon the Lanzi and colleagues’
(2018a) Role Play Activity measure to examine a variety of everyday tasks, but also explored
individual differences using a multiple baseline design. As highlighted in previous research
(Lanzi et al., 2018b) individuals have unique preferences and previous experiences that impact
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functional strategy use. The different baseline levels across participants further confirmed this
finding. Although the participants in dyad 2 were already using strategies prior to intervention,
they still increased EMA use following intervention. Therefore, future research should explore
individual strategy use prior to intervention to better tailor the EMAs to each individual’s needs,
residual strengths, and previous experience with compensatory strategies.
Maintenance of Skills
Participants in dyads 1 and 2 were assessed in one-month increments following
intervention to analyze the retention of functional strategy use. Overall, the participants
maintained strategy use for 1-3 months following intervention as indicated by visual analysis.
This finding is different from the results of Kinsella and colleagues (2009), because their
participants did not maintain treatment effects after 2 weeks. The participants in the current study
may have increased maintenance because of the limited number of strategies taught and multiple
options provided to each participant that encouraged use of preferred EMAs during intervention.
This finding emphasizes the need to provide person-centered interventions and continue to
examine the long-term effects of personalized EMA interventions for individuals with mild
memory impairments.
Self-Perceived Strategy Use
The researchers examined participants’ perception of memory skills through the MMQ
(Troyer & Rich, 2002). The effects of the structured EMA intervention on self-perceived strategy
use were documented for all participants on the MMQ-Strategy. Findings were similar to Lanzi
et al. (2018a) in that participants reported daily strategy use as a result of EMA treatment.
However, inconsistent findings on the other subtests (MMQ-Contentment and MMQ-Ability)
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suggest a possible disconnect between self-report and performance-based measures. This finding
is similar to previous research (Kinsella et al., 2009).
One explanation for the disconnect is the possible memory beliefs or negative stereotypes
about aging memory of the participants (Kinsella et al., 2009). This idea suggests that although
participants have a change in behavior they may need time for accurate self-appraisal of that
change; they may not value the use of strategies; or they may think the use of strategies is a
reflection of memory impairment. The large range in scores amongst participants, however,
suggests that some individuals possibly recognized the change faster than others, or valued the
use of strategies. Therefore, researchers need to continue to enhance participants’ awareness of
the benefits of a strengths-based, strategy approach and to reduce negative stereotypes associated
with aging. Researchers should also explore other methods of examining individual changes
following treatment, such as quality of life measures.
Recent research has described the importance of exploring quality of life in older adults
with mild memory impairments (Smith, Chandler, Fields, Aakre, & Locke, 2018). Smith and
colleagues (2018) surveyed 82 couples (an individual with mild cognitive impairment and their
partner) to examine outcome and intervention preferences. Participants ranked quality of life as
the highest outcome priority and ranked memory compensatory training as the most valuable
component of a multi-faceted behavioral intervention program. It is possible that compensatory
based interventions that focus on person-centered components have an effect on quality of life
(Smith et al., 2018). Future research should explore the relationship between compensatory
interventions and the quality of life of individuals with mild memory impairments.
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Limitations
The study examined a community-based sample; therefore, participants did not have a
formal diagnosis of mNCD (even though the researchers used the DSM-V diagnostic criteria for
mNCD to describe the participants). The lack of formal diagnosis limits the interpretation of the
data and may explain some of the inconsistencies across follow-up performance. Future studies
should evaluate EMA strategy use with larger populations of individuals who have formal
diagnoses. Another limitation was that all of the participants were female and Caucasian; this
may have impacted the dynamics of interactions amongst group members. Future research
should include more diversity amongst participants.
Conclusions
This study employed a single subject design to describe findings of an innovative
structured group EMA treatment for individuals with mild memory impairments living in the
community. Positive treatment effects revealed that individuals with possible mNCD can learn
and maintain EMA strategy use following a treatment that taught several EMAs using a group
approach as documented by the Roleplay Assessment. These findings emphasize the need to
tailor compensatory strategies to meet the participant’s unique needs, residual strengths, and
preferences. The current study also provides initial evidence for using roleplay-based measures
to document treatment effects. More research is needed to investigate the relationship between
roleplay-based measures and everyday performance. It is critical for researchers to continue to
develop and investigate person-centered compensatory interventions aimed to enhance the
cognitive communication skills of individuals with mNCD.
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CHAPTER FIVE: THE DEVELOPMENT AND INITIAL VALIDATION OF THE
FUNCTIONAL EXTERNAL MEMORY AID TOOL
Introduction
Although the number of Americans who experience mild cognitive impairment (MCI) is
rising above 11.6 million (Alzheimer’s Association, 2018), professionals struggle to consistently
assess cognitive deficits and identify functional performance to provide effective treatments for
this population (Petersen et al., 2010). In addition, approximately 32-38% of individuals with
MCI will progress to a major form of dementia within five years (Mitchell & Shiri-Feshki, 2009;
Ward, Tardiff, Dye, & Arrighi, 2013). Thus this prevalence, emphasizes the need to assess early
to ensure meaningful interventions take place (Petersen et al., 2010). Currently, no
pharmacological or impairment-based interventions reduce the rate of cognitive decline for
individuals with progressive impairments (Petersen, 2016). Therefore, lifestyle modifications
(e.g., compensatory strategies) and behavioral interventions are needed to maintain
independence. In fact, according to the DSM-V (American Psychiatric Association, 2013),
individuals with mild neurocognitive disorder continue to manage complex activities of daily
living independently but require compensatory strategies to help maintain independence during
everyday tasks. Therefore, professionals need appropriate assessment tools to examine the
everyday needs/skills and use of compensatory strategies to facilitate independent living into the
future for individuals with mild neurocognitive disorder (Blazer, 2013).
One common compensatory strategy that successfully facilitates increased functional
performance of everyday tasks is the use of external memory aids (EMAs; Sohlberg et al., 2007).
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EMAs reduce the cognitive burden by placing the emphasis on one’s preserved strengths to
retrieve necessary information needed to complete daily tasks (Lanzi, Burshnic, & Bourgeois,
2017). Although there is strong evidence for interventions incorporating EMAs, individuals
rarely sustain these strategies following intervention (Scherer, 2005). Poor maintenance may be
due to the lack of tools available for professionals to assess cognitive strengths and functional
performance to develop person-centered interventions that facilitate improved performance
(Brown, 2018; Hickey & Bourgeois, 2018).
Cognitive Impairment-Based Assessments
The majority of assessment tools used by speech-language pathologists to develop
interventions for individuals with mild neurocognitive disorder are impairment-based (Brown,
2018). Standardized screening tools and assessments examining cognitive impairments may help
to establish a diagnosis (or prognosis); however, they were not designed to inform compensatory
treatment planning (Hickey & Bourgeois, 2018). Unfortunately, professionals continue to rely on
administration of impairment-based tools to develop interventions although researchers and
clinicians have acknowledged the problematic nature of these assessments, including their lack
of ecological validity, sensitivity, and specificity (Turkstra et al., 2005; Ylviasker, Szekeres, &
Feeney 1998; Ylviasker et al., 2001). Exploring these types of tools in further detail may help us
understand where modifications are needed to provide the desired information about
compensatory strategies.
Cognitive screening tools. The Mini-Mental State Exam (MMSE; Folstein, Folstein, &
McHugh, 1975) and the Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005) are
two of the best-known cognitive screening scales. These tools are widely used by a variety of
rehabilitation professionals due to their brevity and ability to describe clients' cognitive global
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functioning (Hickey & Bourgeois, 2018).
Folstein et al. (1975) developed the MMSE to help estimate severity of the cognitive
impairment and document changes in cognition. The screening tool takes approximately five to
ten minutes to administer and the items examine several domains of cognitive function:
visuospatial, language, concentration, memory recall, and orientation (totaling 30 points). During
the MMSE administration, participants complete decontextualized objective tasks (e.g., naming
of three objects and copying intersecting pentagons). Professionals across various disciplines use
the criterion scores to determine the severity levels of cognitive impairment. Although criterion
scores are easy to interpret, the scores are greatly influenced by education, age, and culture and
therefore are not sensitive to detect milder cognitive deficits (Tombaugh & McIntyre, 1992). In
addition, the MMSE does not examine executive functioning skills necessary to complete daily
tasks. This is a major limitation as the use of compensatory strategies is dependent on such skills.
Therefore, Nasreddine et al. (2005) designed the MoCA, a brief cognitive screening tool to
better detect mild impairments (Larner, 2012). The screening tool’s administration time is
approximately 10-15 minutes and the maximum total score is 30 points. Similar to the MMSE,
the MoCA screens a variety of language and cognitive processes (i.e., visuospatial, executive
functions, language, attention/concentration/working memory, memory recall, and orientation)
with decontextualized tasks. Although the MoCA is sensitive to mild impairments, screening
tools provide insufficient information to draw conclusions about the nature of cognitive
impairments or the use of compensatory strategies. Therefore, comprehensive dementia
assessment batteries are often recommended (Moafmashhadi & Koski, 2013).
Comprehensive dementia assessment batteries. Several batteries of cognition exist that
comprehensively assess a client at the impairment level. These assessment batteries examine
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extensively a broad range of cognitive and language domains; however, the specific cognitive
assessments included are decontextualized making it difficult for individuals to understand and
complete the tasks (Mungas, Reed, & Kramer, 2003).
One frequently used comprehensive assessment battery is the Repeatable Battery for the
Assessment of Neuropsychological Status (RBANS; Randolph, Tierney, Mohr, & Chase, 1998).
The RBANS includes 12 subtests yielding six indices (e.g., memory and attention).
Administration of the RBANS takes approximately 30 minutes and was designed to identify
abnormal cognitive decline in older adults. Unfortunately, the tasks within the RBANS are
decontextualized and provide limited information on the executive functioning or functional
performance of individuals with neurocognitive disease.
Bayles and Tomoeda (1993) developed a comprehensive assessment battery: the Arizona
Battery of Communication in Dementia (ABCD). Within the ABCD are four screening tasks and
14 subtests to assess several cognitive-linguistic domains. Although the ABCD is normed with a
large population of individuals, the battery is time consuming, lengthy and not reflective of
functional behavior. Therefore, clinicians rarely administer the ABCD in its entirety (Hickey &
Bourgeois, 2018). To enhance clinical utility, the researchers developed the Functional
Linguistic Communication Inventory (FLCI; Bayles & Tomoeda, 1994) to measure the functional
communication of individuals with moderate and severe forms of dementia. Although the
researchers developed the FLCI to be “functional,” there is little evidence supporting the
ecological validity of the tool. Clinicians also describe the FLCI’s limited use of contextual
supports and cues a disadvantage and not reflective of the interventions typically used with this
population (Johnson & Jackson, 2008).
Each of the cognitive measures described above have two major shortcomings: (1) they are
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not representative of functional performance, and (2) they do not facilitate the development of
compensatory interventions (Hickey & Bourgeois, 2018). Thus, focusing on impairments during
assessment is not an effective approach for individuals with neurocognitive disorder (Holland,
2003). Rather professionals need to use assessment approaches that measure functional cognitive
skills (e.g., executive functioning), social contexts, and activity participation to guide the
development of person-centered interventions. For example, instead of measuring the accuracy
of naming objects or drawing figures, professionals need measures that examine an individual’s
ability to participate in planning for an upcoming doctor's appointment or shopping trip (Eadie et
al., 2006). Thus, researchers suggest the need for speech-language pathologists to consider the
several domains of the World Health Organization’s (WHO) International Classification of
Functioning, Disability, and Health framework and, in particular, examine the domain of
Participation, Environment, and Activity in assessment and interventions of individuals with
mild neurocognitive disorder (Eadie et al., 2006; Hickey & Bourgeois, 2018; WHO, 2001).
Activities of Daily Living Assessments
Individuals with mild neurocognitive disorder, and normally aging adults, may use
compensatory strategies to enhance their activity participation (American Psychiatric
Association, 2013). Therefore, professionals need to assess one’s ability to complete activities of
daily living, noticing whether or not the individual uses a compensatory strategy successfully.
Although a variety of assessments exist that examine activities of daily living, these measures
have several limitations, including the omission of compensatory strategy assessment.
Informant-Based measures. Researchers developed questionnaire scales to examine
individuals with neurocognitive disorders’ ability to complete activities of daily living (Ramsay,
Winget, & Higginson, 1995). Unfortunately, several of these questionnaires (for example the
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Functional Assessment Staging scale; Reisberg, 1988) are designed to stage individuals with
neurocognitive disease along a continuum of 1 to 7. Such staging questionnaires provide little
guidance to rehabilitation professionals designing strengths-based and person-centered
compensatory interventions (Bourgeois, Brush, Douglas, Khayum, & Rogalski, 2016).
In addition, these questionnaires were designed to be completed by a caregiver (e.g., nurse,
family member, or resident assistant). Therefore, the information obtained by questionnaires
includes judgments and biases that may impact the results of the assessment (Bucks, Ashworth,
Wilcock, & Siegfried, 1996). The Disability Assessment in Dementia Scale (DADS; Gélinas,
Gauthier, McIntyre, & Gauthier, 1999) is another questionnaire or interview to be completed with
a caregiver to examine clients’ initiation and performance of daily activities. The 46 items on the
DADS are categorized into three domains: (1) initiation, (2) planning and organization, and (3)
performance. Since the DADS was developed for use in clinical trial research, the clinical utility
of the tool is often questioned (Hickey & Bourgeois, 2018). The interview-based administration
may be too lengthy for a busy clinical setting and the questions do not explore communicationbased domains. Therefore additional tools, such as the Activities of Daily Living Questionnaire
Scale (ADLQ; Johnson, Barion, Rademaker, Rehkemper, & Weintraub, 2004), have been modified
to increase applicability to clinical settings. Although researchers have updated and revised these
questionnaires, it is vital that professionals do not solely rely on informant-based questionnaires,
but rather include the individual with neurocognitive disorder in the assessment process.
Performance-Based measures. Performance-based measures aim to provide professionals
with opportunities to include clients in the assessment by examining task execution in simulated
everyday activities. Therefore, these types of measures are more ecologically valid than
impairment based measures (Hickey & Bourgeois, 2018). The Rivermead Behavioural Memory
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Test-III (RMBT-III; Wilson et al., 2008) is a performance-based measure of everyday memory
functioning within simulated activities of daily living. For example, clients are asked to recall
faces, travel routes, and stories. Although the items are functional, the clients are unable to use
contextual supports or compensatory strategies to complete the tasks. For instance, the RMBT-III
asks the client to remember to retrieve a personal belonging at the end of the examination. This
task is functional because often one has to remember to retrieve a personal belonging; however,
in everyday life strategies are commonly used by individuals to complete the described task. One
may use environmental cues (e.g., placed the item by the door) or an EMA (e.g., wrote down the
words “do not forget umbrella”) to complete the task. Incorporating contextual supports and
compensatory strategies into a measure, with items similar to those in the RMBT-III, may better
assist professionals designing person-centered therapeutic plans that teach compensatory
strategies that sustain following intervention.
Similar to the RMBT-III, the Communication Activities of Daily Living-3 (CADL-3;
Holland, Fromm, & Wozniak, 2017) is a performance-based measure for individuals with
neurogenic communication disorders. The items in the CADL-3 are simulated activities;
however, the items primarily focus on language-based daily activities (e.g., telephone use).
Another commonly used measure is the Texas Functional Living Scale (TFLS; Cullum et al.,
2001), which focuses on instrumental activities of daily living. This test was designed to have
high clinical utility and to be appropriate for individuals with varying levels of Alzheimer’s type
dementia because the items are highly functional and examine participant behavior.
Unfortunately, the TFLS (like the RMBT-III and CADL-3) does not incorporate strategies that
may improve functional performance for individuals with mild memory impairments. Thus,
when assessing for treatment planning, assessments need to be reflective of everyday tasks and
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explore clients’ cognitive communication strengths through compensatory strategies (Hickey &
Bourgeois, 2018).
Compensatory Strategies
As individuals progress from mild to major forms of neurocognitive disease,
neuropathways that once supported cognitive-communication skills begin to deteriorate (Hickey
& Bourgeois, 2018). Therefore, compensatory strategies are useful because they reduce the
burden of impaired processes by providing alternative routes to retrieve stored information to
enhance independent function longer than otherwise possible (Lanzi, Burshnic, & Bourgeois,
2017). Researchers have investigated several types of compensatory strategies to support
individuals across the continuum of the disease, such as, spaced retrieval (Camp & Schaller,
1989), memory wallets (Bourgeois, 1992; 2014), written cues (Bourgeois, Burgio, Schulz,
Beach, & Palmer, 1997), visual cues (Davis & Weisbeck, 2016), and external and internal
memory aids (Stott & Spector, 2011).
External memory aids (EMAs), as described earlier, are an evidence-based cognitive
communication treatment approach that capitalizes on the intact skills or strengths of the
individual (Lanzi et al., 2017). Interventions incorporating EMAs enhance the quality of life and
independence of individuals with neurocognitive disorder (Hopper et al., 2013). Therefore,
researchers recommend teaching EMAs early during the course of the disease (Lanzi et al., 2017;
Lanzi, Wallace, & Bourgeois, 2018). Although researchers have investigated EMA instruction
programs, limited evidence exists to assist professionals in evaluating clients' strategy use prior
to intervention. The lack of measures to examine EMA use could be the reason for limited
sustained strategy use following intervention (Scherer, 2005).
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Self-Report strategy measures. Currently available measures to examine compensatory
strategy use are primarily informant-based or self-report tools. One commonly used
questionnaire is the Multifactorial Memory Questionnaire (MMQ; Troyer & Rich, 2002). The
MMQ is a self-report questionnaire used to assess self-perception of everyday memory
functioning. The MMQ has three factors: Contentment, Ability, and Strategy. Within each factor
are several items (i.e., Contentment=18 items, Ability=20 items, and Strategy=19 items) to
which the respondent rates the items using a five-point scale (strongly agree, agree, undecided,
disagree, and strongly disagree) to indicate the level of agreement. The psychometric properties
conducted on this tool are limited. However, due to the few tools available, the MMQ is often
used in research and clinical practice.
Kinsella et al. (2014), for example, conducted a well-designed randomized controlled
single blind trial and evaluated the effects of a five-week group intervention training a variety of
compensatory strategies. The researchers utilized prospective memory tasks, adapted from the
RMBT-III, to examine functional performance of cognitive skills and the MMQ to examine selfperceived memory skills. The researchers reported a significant medium-size group effect on the
prospective memory tasks during follow-up assessments at two weeks and four months.
However, the group effect on self-reported memory ability on the MMQ was not significant
during either follow-up assessment. The researchers suggest the discrepancies in findings
between the self-report tool and prospective memory tasks may be due to the limitations of selfreport questionnaires (e.g., participant subjective memory beliefs). Thus, relying solely on client
self-report to evaluate strategy use and plan compensatory interventions is insufficient.
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Simulated External Memory Aid Assessment
Currently available assessment measures may provide rehabilitation professionals with
information regarding a specific domain (e.g., cognition or activities of daily living), but each
fails to integrate a strengths-based approach to assessment indicative of real-world activity and
performance that is inclusive of everyday strategies to enhance performance of such tasks.
Therefore, measures that examine functional performance and strengths are necessary to tailoring
treatment plans to individual needs (Hickey & Bourgeois, 2018). One approach to addressing the
gaps in the previously described standardized and subjective measures is to simulate real world
experiences and examine the individual’s responses (both strengths and weaknesses with or
without EMAs) to challenging scenarios typical of daily living.
Lanzi et al. (2018b), for example, developed a simulated assessment task to investigate the
effects of a six-week group intervention, training individuals with mild neurocognitive disorder
to use several EMAs. In addition to self-report and impairment-based tools, the study
incorporated a researcher-designed roleplay activity examining individual compensatory strategy
use within an everyday task (i.e., retrieving information from a pre-recorded voicemail about an
upcoming event). Prior to playing the voicemail, the examiner told participants they could use
any strategy on the table (e.g., paper, timer, calendar) to assist them to retrieve information
following the recording. Participants in the intervention group increased the amount of accurate
information retrieved and strategy use following intervention, as compared to the control group.
This study provided initial evidence for a simulated performance-based functional measure that
incorporated strategy use; however, a single roleplay task was investigated and only group
changes were explored.
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Lanzi and Bourgeois (2018) employed a multiple baseline design across dyads to examine
the individual effects of a three-week intervention training several EMAs. The researchers
expanded the roleplay activity to include three everyday tasks. During the tasks, the participants
were asked to (1) remind the examiner of a specific topic within a stated time interval (e.g., 2
minutes), (2) retrieve information from a voicemail about an upcoming event, and (3) retrieve
information from their calendar about three upcoming events. Throughout each task the
participants had opportunities to use EMAs (e.g., paper, timer, calendar). The participants
increased performance on the expanded roleplay assessment following intervention. However,
each participant performed uniquely, emphasizing the need to develop personalized interventions
to facilitate sustained strategy use. This finding is similar to previously conducted research on
individuals' EMA preferences that described the unique preferences of individuals of similar
lifestyles and emphasized the need to obtain this information prior to selecting EMAs (Lanzi et
al., 2018a).
To enhance the everyday cognitive communication needs of individuals with mild
neurocognitive disorder role-play assessment tools must be expanded to simulate various
everyday tasks for individuals with mild neurocognitive disorder. Similar to items in the
RBANS-III, CADL-3, and the TFLS, the proposed tool aims to simulate everyday tasks, but
incorporates levels of assistance through EMAs. To date, no other measure has examined EMA
use within simulated everyday tasks and measured the psychometric properties for individuals
with mild neurocognitive disorder. In fact, the majority of performance-based tools do not
provide data on validity and reliability for individuals with mild cognitive impairment (Belchior
et al., 2015). Without the proposed assessment, professionals will use inadequate tools to design
compensatory-based interventions without long lasting effects. Thus, the present study aims to
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develop and evaluate the Functional External Memory Aid Tool in order to bridge the gap
between current assessment tools and interventions for individuals with mild neurocognitive
disorder.
Research Aims
Phase 1
1. To develop the item pool for the Functional External Memory Aid Tool
2. To evaluate the content validity of the measure
Phase 2
3. To evaluate the internal structure (dimensionality) of the measure
4. To examine the relationship between the Functional External Memory Aid Tool and
participant demographic variables (i.e., age and education), the MoCA, and MMQ.
Phase 1-Development And Content Validity Of The FEMAT
Operational Definition
The Functional External Memory Aid Tool (FEMAT) item pool was developed using
guidelines presented by Crocker and Algina (2006). The steps outlined below are necessary to
establish content-oriented evidence for the instrument (Lambie, Blount, & Mullen, 2017). First,
an operational definition of the construct of Everyday Strategy Use: examining one’s ability to
use EMAs to compensate for impairments in cognition to enhance the completion of everyday
tasks, was established. This definition was based on a literature review of similar assessments (as
described above). In addition to using the strengths and limitations of the reviewed instruments,
the construct definition is consistent with the WHO's International Classification of Functioning,
Disability, and Health framework for assessing cognition in social contexts (WHO, 2001).
Specifically, the use of strategies examines the domain of Environmental factors and everyday
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tasks are within the domain of Participation. Thus information obtained from the FEMAT is
intended to examine the influence of Environmental factors and Participation on an individual's
Activity performance.
Item Generation for the FEMAT
Next, the initial item pool was generated from five sources: (a) examination of existing
instruments that assess activities of daily living and strategy use; (b) review of the mild
neurocognitive disorder intervention literature focused on compensatory strategies; (c) pilot
studies of simulated functional role play assessment tools (Lanzi et al., 2018b; Lanzi &
Bourgeois, 2018); (d) discussion with experts in the field and individuals with mild
neurocognitive disorder; and (e) evaluation of FEMAT content by cognitive communication
experts.
The RMBT-III, CADL-3, TFLS, and MMQ were reviewed to identify possible items that
could be revised to examine one's use of EMAs to complete everyday tasks. Throughout pretesting, items were reworded to increase clarity and simplicity. Kline's (2005) nine rules for
guiding the development of appropriately written items were considered. Following the initial
review of previous research and similar measures, the initial item pool of the FEMAT consisted
of 15 items and a five-point scoring rubric.
An expert panel reviewed the items to assess item verification. The panel consisted of six
individuals who are content domain experts: (1) an international dementia researcher; (2) a
speech-language pathologist specializing in cognitive communication; (3) a clinical-instructor in
dementia practice for speech-language pathologist; (4) a clinical researcher and certified
educator for Montessori for Aging and Dementia; (5) a neuropsychologist and test development
researcher; and (6) a cognitive communication test development researcher. The reviewers used
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electronic forms with detailed instructions for recording their evaluations on various aspects of
the FEMAT using a 4-point scale (with anchors of 1-not acceptable [major modifications
needed] to 5-exceeds expectations [no modifications needed]) and for narrative
feedback/suggestions. The reviewers rated the following aspects for each item of the FEMAT:
representativeness, clarity of wording, importance in measure the construct, word structure, and
scoring rubric structure. Following independent completion of the review forms, a summary
table of the mean ratings across the six reviewers (refer to Table 5.1) was created. In addition,
the narrative feedback and suggestions from each reviewer were summarized into a statement of
the major concerns for each item (refer to Table 5.1). Then the summary table and statements
were reviewed and each item was revised based on the concerns. Lastly, the FEMAT’s scoring
rubric was revised based on feedback from the expert panel and a developer of the CADL-3.
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Table 5.1. Mean Scores from Expert Reviewers, Summary Statements of Narrative Feedback, and Researcher's Response to
Feedback.
Item
Number
Item 1

Representativeness

4.40

Clarity

3.60

Importance

3.40

Word
Structure
3.80

Scoring
Structure

Summary of Feedback

Response to Feedback

-Necessity of item to construct
-Type of recipe

-Item removed

4.20

-Use of the following terms: me vs. you, initiated
vs. set, verbally vs. initiated

Item 2
4.60

3.75

4.60

4.25

3.80

4.80

4.80

4.80

4.75

4.40

4.40

4.60

4.40

4.50

4.00

4.25

4.00

4.25

4.50

3.50

4.80

4.80

4.80

4.75

3.80

4.60

4.20

4.60

5.00

4.60

-Scoring clarifications, concern with 2-part item
-Measuring accuracy different than measuring
strategy use
-Overall complexity of the task
-Demands on attention
-Use of the following term: show me
-Consider terms on invitation
-Complexity of task components
-Need for prompt in item

4.40

4.80

4.75

4.75

4.25

-Retrieval of components

4.80

4.40

4.80

4.75

4.20

4.60

4.50

4.60

4.50

3.00

4.20

4.80

4.40

4.75

3.20

-Complexity of item materials
-More of an observation task
-Concerns with scoring structure
-Not reflective of daily task
-Scoring dependent on previous items

4.80

4.40

4.60

4.75

4.20

4.40

4.60

4.80

4.50

4.20

4.20

4.20

4.60

3.75

3.40

4.00

4.60

4.00

4.75

3.80

Item 3
Item 4
Item 5
Item 6
Item 7
Item 8
Item 9
Item 10
Item 11
Item 12
Item 13
Item 14
Item 15
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-Concerns with item wording
-Concerns regarding use of pharmacy phone
number
-Difference between appointment and shopping
message
-Discussion on type of EMA use
-Concern regarding importance of item

-Overall scoring revised
-Phrase “show me”
added
-Removed 2-part item
-Overall scoring revised
-Added form to
complete task
-Item removed
-Added “show me”
-Redesigned invitation
-Added prompt
-Revised message
-Added form to
complete task
-Reduced complexity of
bill content
-Item removed
-Item removed
-Reworded item
-Revised to email about
prescription order
-Item restructured
-Item removed

Results
The process of test development and item refinement resulted in 11 items (reduced from
15) designed to explore the overarching construct of Everyday Strategy Use, as shown in
Appendix E. The 11-items were distributed among three factors: Factor 1-Medical Tasks (e.g.,
sorting medications; 3-items); Factor 2-Instrumental Daily Tasks (e.g., remembering details of a
birthday invitation; 4-items); and Factor 3-Retrieval-Based Tasks (e.g., reminding examiner to
complete an upcoming task; 4-items). Each item was developed to simulate everyday tasks
within each specific factor domain. For each item, the participants were asked to "show" the
researcher how he/she would complete the task or retrieve specific information for the task. In
addition, the scoring rubric was revised from a 5-point interval scale to a 4-point categorical
scale. Refer to Appendix E, for the FEMAT’s complete 11-item pool with the 4-point categorical
scoring rubric.
Phase 2-Establish Initial Psychometric Properties Of The FEMAT
Participants
Participants were recruited from several metropolitan areas of Tampa, FL, Pittsburgh, PA,
and Providence, RI, and consisted of a community-based sample of individuals with possible
mild neurocognitive disorder. In each city, fliers were posted and property managers from local
senior centers and independent senior or retirement living complexes were contacted. Property
managers of two senior centers and seven retirement living communities invited the researcher to
give a presentation discussing the study to the older adults in the community. Prior to the
presentation, fliers were posted in each community site aimed to recruit older adults who met the
following inclusion criteria: 60 years or older; self-report of cognitive status change within the
last 6 months to one year; community dwelling; self-report of independence completing activities
99

of daily living; premorbid literacy with English as first language; negative self-reported history
of delirium, stroke, or other acquired neurological condition; and no self-reported formal
diagnosis of dementia. As shown in Table 5.2, recruitment was divided into three phases.
During Phase 1 of recruitment, older adults independently attended the study recruitment
presentation that lasted approximately 30 minutes. In addition to the presentation, the researcher
spoke with interested older adults at each site location throughout the day regarding the study. If
interested, the older adults scheduled a time to meet with the researcher to complete Phase 2 of
recruitment.
Following informed consent, the researcher used a demographic form to guide a semistructured interview with the participant to obtain demographic and basic study eligibility
information. Then, the remaining screening measures were administered: (15-item Geriatric
Depression Scale (GDS; Sheikh& Yesavage, 1986), MoCA, and Functional Vision, Hearing, and
Communication Screening Measure (FunctVHC; Bourgeois, Dijkstra, Burgio, & Allen-Burge,
2001)). To progress to Phase 3 of recruitment the participant needed to meet the following
criteria: a score on the MoCA within the range of MCI (21 to 25) (Nassreddine et al., 2005); a
score less than or equal to 5 of self-reported depressive symptoms on the GDS; and a passing
score on the FunctVHC. If the participant met study criteria, then the individual was included as
a participant in the research study. Screening procedures were conducted individually in a quiet
room at the site location from which the participant was recruited. If the individual consented,
sessions were video-recorded and lasted approximately 30 minutes.
Ninety-nine participants (9 participants per item) were included in the present analyses.
The participants varied in age, sex, race, and level of education. However, majority of the
participants (87%) were Caucasian women. Of the 99 participants, six were men, five were
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African American, and one was Hispanic. The mean age of the participants was 80 (median=80;
range=64-94). The average level of education for the participants was 14 years (range=11-22
years). Their mean MoCA score was 23 (median=22; range=21-25).
Table 5.2. Number of Participants Recruited at Each Site Location.
Site Location

Total Number of
Residents/Seniors

Phase 1
Recruitment

Phase 2
Recruitment

Phase 3
Recruitment

H.C (SC)
90
14
10
6
S.C (SC)
87
25
20
6
S.H (RLC)
106
50
32
23
R.S (RLC)
94
23
17
13
S.S (RLC)
69
12
17
5
P.I (RLC)
68
27
18
12
M.N (RLC)
59
11
7
4
U.V (RLC)
275
50
40
28
R.I (RLC)
102
8
3
2
Note. Each site location was given a pseudo abbreviation; (SC)=Senior Center;
(RLC)=Retirement Living Community; Phase 1=Number of adults who attended the recruitment
presentation or talked with the researcher; Phase 2=Number of adults who participated in
screening procedures; Phase 3=Number of adults included in the study.
Study Procedures
Immediately following screening procedures, the MMQ and FEMAT were administered in
randomized order. During the administration of the MMQ, the participants were instructed to
read the written directions and independently rate (with a written marking) each of the 57 items
using a scale from strongly agree to strongly disagree or from all the time to never depending on
the subtest (i.e., MMQ-Contentment, MMQ-Ability, and MMQ-Strategy). Administration of the
MMQ was approximately 20 minutes.
The 11-item FEMAT (refer to Appendix E) was administered individually to each
participant. First, the researcher placed several EMAs on the table in front of the participant (i.e.,
calendar, notepad, sticky note, timer, pill organizer, and pen). Then, the participant was told that
he/she could use any of the EMAs on the table to help them complete the everyday tasks within
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the assessment. The researcher pointed to and identified each item on the table. The participant
was also told that he/she could use anything with him/her (e.g., phone) to help complete the
tasks. Then the 11-item pool of the FEMAT was administered and each item was scored using a
4-point scale. The items were orally read to the participant and he/she could respond in a variety
of ways (e.g., written, oral, or gestural). The administration of the FEMAT was approximately
10-15 minutes.
Reliability and Fidelity
To examine reliability of the FEMAT, raters were trained to record data while watching the
session video recordings of the FEMAT administration. During training procedures, the raters
were taught how to score each item using the 4-point scale while watching a sample video. Then,
the raters had to each complete the scoring for a FEMAT administration session and score to a
rate of 80% agreement with the researcher prior to independently scoring 20% of the sessions.
The raters used a spreadsheet to score each item. After independent ratings, inter-rater reliability
was conducted by dividing the total number of both raters’ FEMAT scores in agreement by the
total number of raters’ agreement and disagreements; 91% (range=81-100%) point-to-point
agreement was obtained. To examine researcher fidelity, raters were trained to administer the
FEMAT. During training procedures, the raters had to administer the FEMAT and score 100%
accuracy. Following training, fidelity was examined by watching the video recordings of the
FEMAT administrations. The raters used a spreadsheet to document if the researcher accurately
followed the administration guidelines for each item. Researcher fidelity was conducted by
dividing the total number of accurate administrations by the total number of accurate and
inaccurate administrations; 100% accuracy was obtained.
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Results
Aim 3
Following the development of the instrument and evaluation of initial content validity,
the next step was to determine the internal structure of the instrument. Evaluating the internal
structure indicates the degree to which the items appropriately conform and represent the defined
construct (AERA et al., 2014). One method for determining internal structure is conducting a
confirmatory factor analysis. To guide the best practices for confirmatory factor analysis
decision-making the researcher conducted the following steps: a) specification of the model, b)
estimation of the model parameters, c) evaluation of overall model fit, and d) evaluation of
model parameter estimates.
Confirmatory factor analysis. To examine the factor structure the researcher used
Mplus Version 8 (Muthen & Muthen, 2017) to conduct a three-factor confirmatory factor
analysis. The researcher identified the model by setting the first factor loadings to 1.0. The
parameter estimates were determined using robust weighted least squares. To evaluate the model
fit, the researcher used the following indicators: chi-square likelihood ratio statistic, root mean
square error of approximation (RMSEA; Steiger & Lind, 1980), and normed comparative fit
index (CFI; Bentler, 1992). Acceptable fit was determined by RMSEA values less than or equal
to .08 (MacCullum, Browne, & Sugarwara, 1996) and CFI values greater than .95 (Hu &
Bentler, 1999). Multiple fit statistics were used because each has limitations and there is no
agreed upon method for evaluation the lack of fit of a model. In addition, the variability between
and within site locations on each item was explored by computing intraclass correlations (ICC).
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The ICC’s represent the amount of variation between site locations and the degree of clustering
or nonindependence of the data within site locations.
A three-factor correlated model using a diagram (refer to Figure 5.1) was specified. The
three factors were (1) Medical Tasks; (2) Instrumental Daily Tasks; and, (3) Retrieval-Based
Tasks. Factor 1- Medical Tasks were everyday tasks to manage personal health needs; Factor 2Instrumental Daily Tasks were typical everyday cognitive-communication based tasks that
examine independent executive functioning skills (e.g., organization); and Factor 3-RetrievalBased Tasks were atypical everyday tasks that examine memory skills. As seen in Figure 5.1,
each item loads to one of the three factors.

Figure 5.1. Confirmatory factor analysis model.
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The model for the FEMAT inconsistently met standards for good fit (refer to Table 5.3).
The chi-square value, χ2 (41, N = 99) = 68.50, p<.05, indicated a significant lack of fit.
However, the researcher used alternative measures of fit, less sensitive to sample size, to judge
the fit as acceptable. The RMSEA of .08 (MacCullum et al., 1996) and CFI of .95 (Hu & Bentler
1999) are within cutoff values used as a general indicator of acceptable fit.
Table 5.3. Confirmatory Factor Analysis Results for Goodness of Fit.
FEMAT
χ2
df
n
CFI
RMSEA (90% CI)
11-item
68.50*
41
99
.95
.08 (.05-.12)
Scale
Note. CFI=comparative fit index; RMSE= root mean square error of approximation;
CI=confidence interval. *p<.001

Standardized loadings for the FEMAT three-factor correlated model are summarized in
Table 5.4. Each of the factor pattern coefficients (loadings) were statistically significantly
different from zero (p< .01). Standardized factor loadings within Factor 1-Medical Tasks ranged
from .561 to .929, Factor 2-Instrumental Daily Tasks ranged from .496 to .906, and Factor 3Retrieval-Based Tasks ranged from .693 to .904. Across all items, Item 1 had the lowest factor
loading (.496) and Item 2 had the highest factor loading (.929).
The correlations amongst the three factors were examined. The correlations are based on
latent factors that take into account measurement error. Each correlation was positive and
statistically significant (p<.01): r=.656 (Factor 1-Medical Tasks and Factor 2-Instrumental Daily
Tasks); r=.519 (Factor 2-Instrumental Daily Tasks with Factor 3-Retrieval-Based Tasks); and
r=.708 (Factor 1-Medical Tasks with Factor 3-Retrieval-Based Tasks).

105

Lastly, the ICC for the 11 items (refer to Table 5.4) was examined. ICCs can range from
0 to 1.0, with larger values indicating greater clustering effects within site locations (Dedrick &
Greenbaum, 2011). The ICCs ranged from .013 (Item 11) to .250 (Item 1). Both Item 1 and Item
7 were relatively large, which often warrants multilevel analyses (Dedrick & Greenbaum, 2011).
However, due to small number of site locations the values should be interpreted with caution.
Table 5.4. Item Descriptives, Item-To-Total Correlations, Intraclass Coefficients, and
Standardized Estimates (Loadings).
Factor
Factor 1:
Medical Tasks

Item
Item 2. Dr. Appointment Voicemail
Item 3. Dr. Appointment Form
Item 8. Medication Management

M(SD)
.72(1.03)
1.39(.79)
1.88(.92)

ICC
.081
.019
.064

I-T r
.51
.49
.34

Estimate
.929*
.683*
.561*

Factor 2:
Instrumental
Daily Tasks

Item 1. Laundry Time
Item 4. Party Invitation
Item 7. Bill Management
Item 10. Email Notice

1.30(1.06)
1.50(.98)
.83(.82)
1.22(1.06)

.250
.079
.129
.094

.40
.52
.49
.55

.496*
.906*
.585*
.643*

Factor 3:
Retrieval-Based
Tasks

Item 5. Store Request Video
Item 6. Store Request Form
Item 9. Reminder Task
Item 11. Retrieval of Reminder Task

.83(1.09)
1.53(.84)
.81(1.23)
1.85(.89)

.037
.023
.072
.013

.59
.51
.61
.65

.803*
.693*
.885*
.904*

Cronbach's alpha
Factor 1 Cronbach's alpha (CI)
Factor 2 Cronbach's alpha (CI)
Factor 3 Cronbach's alpha (CI)
11-item scale Cronbach's alpha (CI)

.63 (.48-.74)
.70 (.60-.79)
.78 (.70-.84)
.84 (.78-.88)

Note. M (SD)=mean (standard deviation); I-T r=item-to-total correlation; CI=confidence
interval; ICC=intraclass coefficient. *p<.001
Internal consistency. Cronbach’s alpha for each factor and total 11-item scale were
examined for internal consistency using SPSS Version 25. As shown in Table 5.4, Cronbach’s
alpha for each factor was found to be acceptable (George & Mallery, 2003): Factor 1 (3 items) α
=.63 (.48-.74), inter-item correlation ranged from .269 to .521; Factor 2 (4 items) α =.70 (.60.79), inter-item correlation ranged from .315 to .486; and, Factor 3 (4 items) α =.78 (.70-.84), the
inter-item correlation ranged from .333 to .626. The 11-item FEMAT was found to be highly
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reliable (11 items: α =.84(.78-.88)). The item-to-total correlations for the items within each of
the three factors were also examined. All 11-items demonstrated adequate item-to-total
correlations (range=.34-.65).
Aim 4
The relationship between the FEMAT and additional factors was examined using SPSS
Version 25 to conduct correlation analyses to evaluate correlation coefficients. The relationships
of the FEMAT score of each factor to the MoCA, MMQ-Contentment, MMQ-Ability, and
MMQ-Contentment scores were also examined.
Demographic variables. The relationship between specific demographic variables (e.g.,
age and education level) and the score of each factor of the FEMAT was measured. As shown in
Table 5.5, results indicated a direct relationship between the education of participants and the
score on each factor of the FEMAT, Factor 1, r=.333, p<.001; Factor 2, r=.114, p>.05; Factor 3,
r=.329, p<.001. Results indicated an inverse relationship between the age of participants and the
score on each factor of the FEMAT, Factor 1, r=-.426, p<.001; Factor 2, r=-.474, p<.001;
Factor 3, r=-.254, p<.001.
Additional assessment measures. The relationship between the participants' score on the
MoCA and the score on each factor of the FEMAT was also examined: Factor 1, r=.352,
p<.001; Factor 2, r=.394, p<.001; and Factor 3, r=.250, p=.01. The correlation analysis for
MMQ-Contentment indicated an inverse correlation between the participants' score on MMQContentment and the score on each factor of the FEMAT: Factor 1, r=-.143, p>.05; Factor 2, r=.188, p>.05; and Factor 3, r=-.215, p=.03. The correlation analysis for MMQ-Ability also
indicated a negative relationship between the participants' score on MMQ-Ability and the score
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on each factor of the FEMAT: Factor 1, r=-.343, p<.001; Factor 2, r=-.296, p<.001; and Factor
3, r=-.282, p<.001. Lastly, the MMQ-Strategy correlation analyses revealed a direct relationship
between the participants' score on MMQ-Strategy and the score on each factor of the FEMAT:
Factor 1, r=.262, p<.001; Factor 2, r=.165, p>.05; and Factor 3, r=.250, p=.01. Each correlation
analysis is reported in Table 5.5.
Table 5.5. Correlations of Education, Age, MoCA, and MMQ.
Factor
Education
Age
MoCA MMQ-C MMQ-A MMQ-S
Factor 1
.333*
-.426*
.352*
-.143
-.343*
.262*
Medical Tasks
Factor 2
.114
-.474*
.394*
-.188
-.296*
.165
Instrumental
Daily Tasks
Factor 3
.329*
-.254*
.250*
-.215*
-.282*
.250*
Retrieval-Based
Tasks
Note. MoCA=Montreal Cognitive Assessment; MMQ-C=MMQ-Contentment; MMQ-A= MMQAbility; MMQ-S=MMQ-Strategy. Coefficients with * are significant (p<.001).
Discussion
The present study describes the development of the FEMAT intended to meet the clinical
need for a validated tool to measure everyday EMA use. The tool provides information about
individuals with possible mild neurocognitive disorders’ use of strategies to enhance
performance of several types of tasks. The study also provides preliminary evidence for the
development and psychometric properties of the FEMAT.
The first aim was to develop the initial item pool for the FEMAT. Similar to other
performance-based functional measures, the initial 15-item pool represented everyday tasks
typical of older adults. For example, both the TFLS and the FEMAT include items simulating
tasks related to bill management, using a calendar, and medication management. However, the
items of the FEMAT were designed to improve upon the limitations of the currently available
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measures to help clinicians better design compensatory interventions teaching EMAs (Blazer,
2013; Brown, 2018; Hickey & Bourgeois, 2018). To enhance clinical utility the researcher
developed a small number of items, included materials realistic of everyday life (e.g., electric
bill) and developed a scoring method that reflects actual behavior and level of assistance (i.e.,
EMA use) needed to complete daily tasks. Unlike other measures, the FEMAT was designed to
evaluate EMA use to enhance outcomes of this type of intervention with individuals with mild
memory impairments. Therefore, scores on the FEMAT depict one’s use of strategies and
everyday task performance.
Next, to explore the second aim the researcher evaluated the content validity of the 15item pool using an expert panel review. As shown in Table 5.1, the mean rating scores of the
reviewers highlight the high level of representativeness and importance of the 15-items in
measuring everyday EMA use. The major concerns of the reviewers (as indicated by summary
statements) were the lack of a strategy prompt within the items, the inclusion of items that were
too complex or not typical daily tasks, and the scoring structure. Thus, the researcher reduced the
15-item pool to 11-items, revised the items to include the prompt “show me,” designed items
within three categories of daily tasks, and restructured the scoring to a 4-point categorical scale.
To date, no other performance-based measure has used the prompt “show me” and scored the
level of EMAs needed to complete daily tasks for individuals with mild neurocognitive disorder.
In addition, compared to the TFLS (21-items), RMBT-III (14-subtests), and CADL-III (50items), the FEMAT has fewer items (11-items). Therefore, the administration of the FEMAT is
relatively short (approximately 10-15 minutes). This is a major strength as clinicians often
discuss the poor clinical utility of available measures due to their extensive length, thus, relying
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on inappropriate measures (e.g., the MoCA) to guide the development of interventions (Brown,
2018; Hickey & Bourgeois, 2018; Turkstra et al., 2005; Ylviasker et al., 2001).
The confirmatory factor analysis (aim 3), confirmed the proposed correlated three-factor
model to examine everyday strategy use (refer to Table 5.3 for goodness of fit values). Factor 1Medical Tasks contained three items and represented tasks related to medical appointments and
medication management. Factor 2-Instrumental Daily Tasks contained four items and
represented tasks related to typical daily executive functioning skills. Lastly, Factor 3-RetrievalBased Tasks contained four items and represented tasks that are atypical and examine memory
skills. Although the results support three separate factors it is important to note that the
correlations between the factors were statistically significant. Therefore, there is a positive
relationship between the three factors designed to examine everyday strategy use.
Examination of the standardized estimates, in Table 5.4, indicated that the items loaded
appropriately to each factor. Although, each item was statistically different from zero it is
important to discuss the items with lower loadings to enhance the overall item-pool. The
estimates of Items 1 (Laundry Time), Item 7 (Bill Management), and Item 8 (Medication
Management) were below the cutoff value of .60. In addition, both Item 1 and 7 had relatively
large ICC values. Therefore, the video recordings of FEMAT administrations were examined to
explore the participants’ functional behavior during these items.
During Item 1, the participants were asked to show the researcher how they would
remember to check the dryer in 10 minutes. Often the participants discussed being unable to
leave their laundry due to theft or building rules, therefore, the older adult would not rely on a
timer to complete the task. Rather, the participants would wait and listen for the alarm on the
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machine. Thus, future research should examine how to prompt one’s use of a timer using a
different simulated task that is not potentially sensitive to site location. Within Item 7,
participants were asked to show the researcher how they would pay specific bills on time. After
listening to the video recordings, participants often described enrolling in “auto pay” to complete
the task. To enhance this item, the researcher should consider redefining the scoring to include a
wider array of strategies (e.g., auto-pay or bill organizers). During Item 8, participants were
asked to sort medications using a pill organizer. Unlike the other items, the researcher explicitly
prompts the participants to use the organizer, which could account for the lower loading. In
addition, after listening to the video recordings the researcher was surprised by the vast
differences in strategies used by participants to sort medications. Future research, should further
explore these descriptions to help refine this item. In addition, researchers could examine trends
across the strategies described to help develop appropriate techniques for medication
management.
To examine the randomness in the data, Cronbach’s alpha was applied. As indicated in
Table 5.4, these analyses revealed reliability scores on Factors 1-3 and the 11-item pool. Thus, at
least 63-84% of the total within-test score variance was due to true score variance. Typically,
alpha values of .70 or higher indicate acceptable internal consistency (George & Mallery, 2003).
Thus, the alpha values for Factor 2, Factor 3, and the 11-item pool were highly reliable. The
lower alpha value (.63) of Factor 1 could possibly be due to the small number of items within the
factor. In addition, the item-to-total correlations (range=.34 to .65) suggests each item is
measuring the construct well and no item should be removed (Nurosis, 1994).

111

Lastly, to explore aim 4 correlation analyses were conducted and interpreted using
guidelines suggested by Cohen (1988). The correlation analyses revealed a weak positive
relationship between education and FEMAT factor scores. Cullum et al. (2014) also found a
positive relationship between education and the TFLS; however, the relationship was moderate
in size. This difference could possibly be due to the high level of education (mean=14 years) of
participants in the present study. Unlike previous research (Cullum et al., 2014; Troyer & Rich,
2002), there was an overall negative moderate relationship between age and FEMAT factor
scores. Thus, the younger the participants were the more strategies they used. This could
possibly be due to the rising use of technology (e.g., smartphone) amongst older adults (Mitzner
et al., 2010). In addition, the age of the participants in the present study (range=64-94) was larger
than Cullum et al.’s participants’ age span (range=64-85). Future research should control for
these demographic factors and recruit participants within specific age groups to further examine
the relationship between age and the FEMAT factor scores.
The relationships between the FEMAT factors, MoCA, and MMQ were also examined.
Correlation analyses reveled an overall weak positive relationship between the MoCA and the
FEMAT. As expected, there was a relationship between the measures (indicating the overlap
between cognitive skills and task performance); however, the relationship was weak. These
findings emphasize the need to include the FEMAT in clinical assessments to examine one’s
strategy use to complete daily tasks because screening measures are not capturing such skills. In
addition, the correlation analyses of the MMQ-Contentment and MMQ-Abilities revealed a weak
negative relationship to the FEMAT factors. Therefore, the worse someone feels about his or her
memory and the more mistakes he or she reports the more strategies they are using to
compensate and enhance performance on everyday tasks. Often participants reported that their
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memory was not good, but described how they always use strategies. Participants also discussed
using strategies to not make the everyday mistakes they reported. Therefore, relying on the
MMQ subtest scores in isolation is not reflective of functional behavior. Previous research has
also reported a disconnect between an individual’s self-report of contentment and abilities and
one's strategy use (Bourgeois, 2013; Kinsella et al., 2001). Thus, in addition to exploring
additional ways to examine strategy use, treatments need to focus on improving one's satisfaction
with using strategies to compensate for impairments.
Limitations
While the present study provides preliminary evidence to support the development and
initial psychometric properties of the FEMAT with individuals with possible mild
neurocognitive disorder, several limitations indicate avenues for future research. One issue that
should be considered prior to interpreting the results concerns the representativeness of the
sample. First, the sample size and demographics of the participants limit the generalizability of
the findings. Specifically, the individuals in the study were primarily Caucasian and female.
Although women make up approximately two-thirds of patients who have Alzheimer’s disease
(Hebert, Weuve, Scherr, & Evans, 2010) and progress at a faster rate from mild to major
neurocognitive disorder (Holland, Desikan, Dale, & McEvoy, 2013), future research should aim
to include more males to examine the relationship between sex and FEMAT scores.
The researcher examined a community-based sample of individuals who met the DSM-V
criteria (American Psychiatric Association, 2013) for mild neurocognitive disorder. Therefore,
the participants did not have an official diagnosis of mild neurocognitive disorder. Although the
diagnosis of the impairment is often criticized and inconsistent (Petersen, 2016), future research
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should consider including individuals with official diagnoses to enhance the generalizability of
findings. In addition, future research should examine the FEMAT performance differences
across the continuum (mild to major) of the disorder to enhance the psychometric properties for a
range of impairments. This could help clinicians to better design interventions for individuals
with possible progressive impairments across the course of the disease.
The present study only examined one population of individuals who use EMAs.
However, EMAs are also an evidence-based strategy frequently used with individuals with
acquired impairments due to stroke or traumatic brain injury (Cicerone et al., 2011; Sohlberg &
Mateer, 1989). Those individuals were excluded from the present study; therefore, it is unknown
if the FEMAT is appropriate to use with individuals with other acquired neurological
impairments. Therefore, future research should explore the use of the FEMAT with these
populations.
Similar to other measurement studies in the field of communication disorders (Hula et al.,
2015), the present study excluded participants with depression (a score of ≥ 5 on the 15-item
GDS). Given the high prevalence of depression among individuals with MCI (Lyketsos et al.,
2002), future research should consider including individuals with depression. Furthermore,
Modrego & Ferrandez (2004) reported a higher rate of conversion to dementia for individuals
who are depressed than those who are not (85% of depressed patients and 32% of non-depressed
patients converted to dementia). Therefore, examining the FEMAT’s psychometric properties in
the presence of depression is necessary for future research.
Although the present study’s findings offer preliminary evidence for the FEMAT, future
research should investigate additional methods of assessing validity and reliability. Based on the
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ICC, for example, a future study could increase the number of participants and site locations to
better control for possible site location effects on item performance. In addition, researchers
could assess construct validity by examining the relationship between performance on the
FEMAT and TFLS. To enhance assessment of reliability, future research should examine the
stability of item scores over time through test-retest analysis.
Clinical Implications
The FEMAT was designed to address the gaps in currently available measures to help
guide clinicians to develop person-centered compensatory-based interventions. The goal of such
person-centered intervention is to promote sustained EMA use since the majority of participants
do not use the strategies following intervention (Scherer, 2005). Thus, a longitudinal study is
needed to examine participants' sustained strategy use from interventions designed using the
FEMAT vs. other performance-based (e.g., TFLS) and impairment-based (e.g., ABCD)
measures. Unlike commonly used performance-based and impairment-based measures, following
administration of the FEMAT clinicians will have information regarding the patient’s
performance of everyday tasks and use of EMAs. This information is critical for treatment
planning to help guide person-centered interventions.
For example, Sohlberg and Mateer (1989) developed a three-step approach to teaching
EMAs. During this approach, the clinician teaches the client about the features of the aid, then
they role-play through scenarios using the aid, and lastly use the aid in one's home environment.
Although this approach describes a linear process for teaching EMAs, not all clients may have to
start at step one (i.e., acquisition phase). For example, maybe the client already uses a calendar
but struggles with how much information to write, or perhaps he/she attempts to use a timer but
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has difficulty with accuracy. The individuals in these examples would need assistance to modify
their use of strategies to enhance performance. However, often clinicians do not obtain this
information until treatment has begun resulting in insufficient use of therapy time. Therefore, the
FEMAT was designed to provide clinicians with this type of information during the assessment
phase of rehabilitation. Specifically, the FEMAT will provide clinicians with information
regarding EMA use during medical, instrumental daily, and retrieval-based tasks. More
research, however, is needed to guide clinicians on how to interpret the FEMAT scores and use
the information to guide interventions that promote sustained strategy use.
Future research should also examine the clinical utility and validity of the FEMAT.
Although the FEMAT was designed to address the gaps in current assessment practices, it is
unknown if the FEMAT provides adequate information to guide person-centered interventions.
Therefore, future researchers should ask clinicians to report their satisfaction with the
information yielded from the FEMAT to develop person-centered interventions.
One surprising discovery from listening to the video recordings of the FEMAT
assessment, was the amount of information participants discussed regarding their everyday use
of EMAs. For example, during Item 7 the participants would often discuss how they managed
their own bills in their home environment or during Item 8 they would describe their medication
management strategy as they were sorting the medication in the simulated task. Thus, in addition
to serving as a performance-based measure the FEMAT also prompted discussion similar to a
patient-centered interview. Future research should examine the content within the video
recordings to analyze themes that may emerge regarding individual at-home strategy use.
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Conclusions
The present study aimed to develop and investigate the initial psychometric properties of
the FEMAT. The results suggest that the FEMAT’s 11-item pool may provide reliable and valid
assessment of everyday EMA use in individuals with mild neurocognitive disorder. The FEMAT
was designed to be used in clinical settings and potentially to be an improvement over currently
available cognitive communication measures because it is based on a strength-based framework
to examine functional behavior and level of assistance using EMAs. By being able to examine
functional skills and strategy use during assessment, we intend to better design interventions for
those with mild memory impairments.
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CHAPTER SIX: CONCLUSIONS
The present multi-manuscript dissertation aimed to develop and examine external
memory aid assessment and treatment approaches for individuals with mild neurocognitive
disorder. Current rehabilitation approaches, for the 11.6 million Americans who experience the
disorder (Alzheimer's Association, 2018), are not person-centered or designed to enhance and
maintain functional behavior. Thus, the everyday cognitive communication needs of individuals
with mild neurocognitive disorder are not met and clinicians are using inadequate assessment
tools to develop goals without long lasting effects (Blazer, 2013; Scherer, 2005). In addition this
disorder is possibly progressive, emphasizing the need for cognitive communication approaches
to be proactive and incorporate a strength-based approach (Petersen et al., 2010). The findings
from the present dissertation describe innovative person-centered assessment and treatment
approaches that incorporate external memory aids to enhance everyday task performance of
individuals with mild neurocognitive disorder. Such approaches will facilitate future research on
the development of a decision-making framework intended to guide clinicians towards designing
individualized treatment plans that promote clients to continue to use strategies to maintain
independence. This dissertation represents the initial development of both assessment and
intervention tools that clinicians could use that are consistent with this innovative approach to
serving their clients with mild neurocognitive disorder.
Simulated assessment approaches that examine external memory aid use, such as the
tools described in the current dissertation, were designed to account for the limitations of
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commonly used measures. Specifically, currently available tools do not reflect a person's subtle
cognitive changes in everyday tasks and do not inform compensatory treatment planning (Hickey
& Bourgeois, 2018; Turkstra et al., 2005). Thus, as shown in Figure 6.1, this dissertation
described the development of three simulated assessment tools that examine one's use of
strategies to complete everyday tasks.
In Chapter 2 the Role Play Activity was designed to measure retrieval-accuracy and
strategy use during an everyday activity (i.e., voicemail retrieval). This tool was the first to
measure task performance and external memory aid use; however, it only explored one type of
task. Thus, in Chapter 4 the Roleplay Assessment explored additional daily activities (i.e.,
reminder-task, voicemail task, and calendar adherence). This assessment provided initial
evidence for measuring one's strategy use through different types of simulated tasks.

Role Play
Activity

Roleplay
Assessment

Functional External Memory
Aid Tool

• Voicemail
Task
• Total= 7
points

•
•
•
•

•
•
•
•

Reminder Task
Voicemail Task
Calendar Task
Total= 14
points

Medical Tasks: 3 Items
Instrumental Daily Tasks: 4 Items
Retrieval-Based Tasks: 4 Items
Total= 11 items, 33 points

Figure 6.1. Simulated assessment tools of everyday external memory aid use.
The measures described in Chapters 2 and 4, were used to document treatment effects.
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Although using functional outcome measures are important, the findings from Chapter 3
described the necessity of examining personal preferences and everyday performance within the
assessment phase of care. Prior to the findings from Chapter 3, it was unclear if individuals with
mild neurocognitive disorder had unique external memory aid preferences.
Therefore, in Chapter 5 the Functional External Memory Aid Tool was designed to
examine one's use of strategies and preferences prior to developing treatments. The tool
simulates everyday activities within three task domains (i.e., Medical Tasks, Instrumental-Tasks,
and Retrieval-Based Tasks). In addition, a uniform scoring rubric was developed to examine
strategy use and retrieval accuracy. To date, no other measure has examined one's use of memory
aids using a functional approach. The initial findings on the psychometric properties of the
Functional External Memory Aid Tool represent the innovative design of the functional measure.
This innovative person-centered measure restructures current assessment practices and provides
initial data to facilitate the use of the Functional External Memory Aid Tool in clinical settings.
Person-centered approaches are necessary in both the assessment and treatment phases of
care (Hickey & Bourgeois, 2018). Thus, this dissertation described two person-centered
interventions for individuals with mild neurocognitive disorder. The group external memory aid
treatment, examined in Chapter 2, evaluated a six-week treatment delivered in a group-format
that enhanced the use of high and low-tech memory aids. In addition, the structured external
memory aid treatment, examined in Chapter 4, evaluated a four-week treatment delivered in
dyads that enhanced individualized use of strategies in everyday tasks. Both studies contributed
to the limited literature base exploring cognitive communication treatment for individuals with
mild neurocognitive disorder and were the firsts to teach solely external memory aids in a group128

format. Speech-language pathologist can use these treatment approaches to deliver interventions
for individuals with mild neurocognitive disorder that promote independence.
Taken together, the results of this dissertation meet the needs of both clients and
clinicians by describing a framework of assessment and treatment approaches for individuals
with mild neurocognitive disorder. Both the assessment and treatment approaches examined in
this dissertation aimed to restructure current practices from impairment-based to activity and
person-centered focused. Therefore, clinicians can begin to implement this framework as an
advancement over previously used approaches. To further this line of research, the next step is to
evaluate a decision-making model to guide the delivery of person-centered interventions
teaching external memory aids that promote sustained strategy use. Below is an illustration (refer
to Figure 6.2) and description of one possible approach for the decision-making model.

Figure 6.2. Functional External Memory Aid Tool decision-making framework.
This proposed model is described using the factors of the World Health Organization's
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(WHO) International Classification of Functioning, Disability, and Health (WHO, 2001) rarely
explored in cognitive assessments: participation, environmental factors, and personal factors.
Clinicians must assess each domain to guide the development of interventions that impact
functional activity. This model facilitates clinicians to use the Functional External Memory Aid
Tool to examine each domain and use the data to develop personalized interventions.
To understand how clinicians can use the proposed model to design interventions, the
following text will describe an example. After administering the Functional External Memory
Aid Tool the clinician will complete Figure 6.2 by documenting information within each shape.
First, the score for each factor will be calculated and written in the factor circles. Since each
factor represents a type of daily task, the score provides information about the client's
participation. Specifically, the score will indicate if the client described using strategies,
attempted to use strategies, or accurately used strategies to participate in everyday tasks. Next, in
the squares, the types of external memory aids (e.g., electronic calendar or manual timer) the
client described using or used during the assessment will be documented. This information will
depict the client's environmental factors that enhance activity performance. In addition, any
information that may be unique to the client's environment will also be documented. For
example, the apartment complex may not allow residents to leave the dryer unattended;
therefore, a timer is unlikely to be used to retrieve the laundry. Next, in the trapezoid, specific
details regarding the use of memory aids use will be documented to explore personal factors. For
example, information about organization of calendar, structure of medication management, and
speed of input are important personal factors that influence strategy success and use. Lastly, the
information documented on the framework shapes will be analyzed to decide the stage to begin
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treatment (i.e., acquisition, application, and adaptation), the types of external memory aids,
individual factors to consider, and the types of daily activities to target. Therefore, by using this
model the treatment plan will be personalized and designed to meet the client's unique needs.
Using this type of framework will help clinicians to design person-centered interventions
that facilitate clients to continue to use external memory aids following treatment. Thus, the
findings from the present dissertation will enhance the overall care of individuals with mild
neurocognitive disorder and promote the design of treatments that maximize independence.
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Appendix A: Role Play Activity Transcript
Voicemail:
"I am calling on behalf of Dr. Matthew's office for your upcoming podiatry appointment on
December 21st at two-o-clock. If you need to cancel please call (401)-523-8676. Please bring
with you your driver's license and insurance cards to the doctor's appointment. If you could
arrive a half an hour in advance so we can go over paperwork that would be best. Thank you and
I look forward to seeing you."

Questions:
1. What is the name of the Doctor you have an appointment with?
2. When is the appointment?
3. What type of doctor's appointment is it?
4-5. What do you need to bring to the appointment?
6. When do you need to arrive at the appointment?
7. What number can you call the cancel?
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Appendix B: Acquisition Handout 1
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Appendix C: Roleplay Assessment Score Sheet

Roleplay Assessment Score Sheet
Date:
Participant ID:

Session #:
Script #:
Task

Question/Prompt

Accuracy

Reminder Task

1. Can you remind me in
________ minutes that I need to
give you _______?

Set a Timer: /1

Voicemail Task

Calendar Task

2.
a) Hi, My name is
_________and I am calling on
behalf of Dr. ________ office.
b) You have a __________
appointment
c) scheduled for ______at
d) _________ o’clock.
e) Please bring your _____ and
_______with you to the
appointment.
f) If you need to reschedule
please call (___)-__________________.
3. Would you mind showing me
what events you have in your
calendar this month?

Reminded of Task:

a)

Notes

/1

Dr’s Name: /1

b) Appointment Type: /1
c) Appointment Date: /1
d) Appointment Time: /1
e) Items to bring: /2

f)

Phone Number: /1

Used a Strategy: /1
Brought in Calendar: /1
Event A: /1
Event B: /1
Event C: /1

Total Score:
_____/14
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Appendix D: Acquisition Handout 2
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Appendix E: FEMAT 11-Item Tool and Materials

FUNCTIONAL EXTERNAL MEMORY AID TOOL
Materials Needed:
• Calendar (monthly and daily)
• Timer (Manual and Portable)
• Notes (notepad, memory wallet, journal)
• Materials Booklet
• Voicemail Recordings
• Voice Recorder
• Pen
• Highlighter
• Medication Organizer
• Pill Bottles
All Materials should be placed on the table within the individual’s reach and sight.

Introduction Directions:
1. Introduce yourself "Hi my name is

"

2. "I'm going to ask you to role play through several everyday tasks today. Please feel free to
use anything on the table or with you to help you complete the tasks (gestures to the items).
There are calendars, timers, medication organizer and notepads. Let's get started. Throughout
each task you can refer to anything you have used."
Items
1. "Pretend you just put your clothes into the dryer. Show me how you would remember
to check the dryer in 10 minutes?"
0-No response
1-Verbally explained he/she would use a strategy (e.g., set timer)
2-Attempted to set timer or write task information
3-Accurately set timer to 10 minutes
Qualitative Observations/Information:
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2. "I am going to play a voicemail for you and ask you some questions about the
voicemail immediately after it stops. The voicemail is about an upcoming appointment"
0-No attempt to use a strategy
1-Attempted to use a strategy (e.g., notepad) during the task
2-Wrote/typed some of the bold words from voicemail transcript
3-Accurately wrote/typed all five bold words from the voicemail transcript
Qualitative Observations/Information:

3. "Now I would like you to fill out this form about facts from the voicemail." (Hand the form
and pen to the participant)
0-No accurate facts documented
1-Accurately documented one-two facts on the form
2-Accurately documented three-four facts on the form
3-Accurately documented five facts on the form
Qualitative Observations/Information:

4. "You just received an invitation to an upcoming party (gesture to the paper
invitation). Show me how you would remember the information for the party?"
0-No attempt at task
1-Verbally explained he/she would use a strategy (e.g., calendar)
2-Attempted to use a strategy to write some of the invitation information
3-Accurately documented the key components of the information on a calendar
(Key components: correct date, time, location, and type of party)

Qualitative Observations/Information:
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5. "A family member just left you a video message asking you to buy something for her
next time you are at the store. I am going to ask you some questions about the message after
I play the message." (play video)
0-No attempt to use strategy
1-Attempted to use a strategy (e.g., notepad) during the task
2-Wrote/typed some of the bold words from message transcript
3-Accurately wrote/typed all five bold words from the message transcript
Qualitative Observations/Information:

6. "Now I would like you to fill out this form asking questions about the facts from the
voicemail." (Hand the form and pen to the participant)
0-No accurate facts documented
1-Accurately documented one-two facts on the form
2-Accurately documented three-four facts on the form
3-Accurately documented five facts on the form
Qualitative Observations/Information:

7. "You just received some bills in the mail (gesture to the bills). On each bill is the type of
bill, due date, and amount due. Show me how you would remember this information to
pay the bills on time."
0-No attempt at task
1-Verbally explained he/she would use a strategy (e.g., calendar)
2-Attempted to use a strategy (e.g., calendar or notepad) to write some of the key
bill components
3-Accurately documented the key components of each bill on a calendar
(Key components: correct date, amount due, and type of bill)
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Qualitative Observations/Information:

8. "These pill bottles contain information about when to take the medications (gesture to
pill bottles and pill organizer). Show me how you would use this pill organizer to
remember to take these medications."
0-No attempt at task
1-Verbally explained he/she would use a strategy (e.g., calendar)
2-Attempted to use the pill organizer to sort some of the medications
3-Accurately used the pill organizer to place the medications in the correct day/time
slot
Qualitative Observations/Information:

9.

"I am going to set the timer for two minutes for you to remind me to complete a task
(set timer for three minutes). I want you to remind me to tell Amanda to call the
insurance company before 5:00.”
0-No attempt to use a strategy
1-Attempted to use a strategy (e.g., notepad) during the task
2-Wrote/typed some of the bold phrases
3-Accurately wrote/typed all of the bold phrases
Qualitative Observations/Information:
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10. "You received an email that your prescription will be ready for pickup tomorrow at 3:30
(gesture to email). Show me how you would remember to pick up your medication on
time.”
0-No attempt at task
1-Verbally explained he/she would use a strategy (e.g., calendar)
2-Attempted to use a strategy to document the information
3-Accurately documented the correct date, time, and a statement to indicate that the
medication will be ready
Qualitative Observations/Information:

11. (Timer goes off). “What did you need to remind me to do?”
0- No attempt at task
1-Attempted task with inaccurate information
2-Attempted task with some of the correct phrases (i.e., “tell Amanda” “call
insurance” “before 5:00”)
3-Accurately stated “tell Amanda” “call insurance” “before 5:00”
Qualitative Observations/Information:
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MATERIALS
Voicemail Script
Hi, My name is Sarah and I am calling on behalf of Dr. Matthew's office. You have a cardiac
appointment scheduled for November 15th at 4 o’clock. Please bring your medication list with
you to the appointment. Also, please arrive 30 minutes in advance to complete the paperwork
prior to the appointment. If you need to reschedule please call us. Thank you and we look forward
to your visit.
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DOCTORS APPOINTMENT

This form is about the information you heard from the voicemail just played.
Please complete the form below to the best of your ability.

Doctor's Name: _________________________________________

Appointment Type: _________________________________________

Date of Appointment: _________________________________________

Arrival Time: _________________________________________

Need to bring to appointment:
__________________________________________________________________
_
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Invitation
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Video Message Script
“Hi! I hope everything is going well with you. I need you to do me a favor and pick up an outfit
for Jacob. He is growing so fast and needs new clothes for our beach trip to Myrtle. He wears
size 4t. It would be great if you could pick him out a swimsuit with a shirt. I am going to email
you a coupon to the store. We need the clothes by Thursday of next week. Thank you so much.”
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MESSAGE QUESTIONS
Please answer the questions below. The questions are about the message you just
heard. Please answer the questions to the best of your ability.

1. Who is the outfit for?

_________________________________________
2. What size do you need to buy?

_________________________________________
3-4. What do you need to buy?

_________________________________________
5. When do you need to buy the outfit by?

_________________________________________
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Due Date
August 13th

Amount Due
$111.17

Account Information
Service Address:

Account Number:
0033881313-03

15210 AMBERLY DR
APT 1734
TAMPA, FL 33647-2194

Customer Code:
8217

Current Month
Previous Balance and Payments
Previous Balance
Payment Received - N/A
Current Monthly Services
Other Surcharges, Fees and Adjustments
Governmental Taxes, Surcharges and Fees

0.00
0.00
80.00
21.71
10.00
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Contact
Us
Online:
brighteelec
t.com
Phone
Customers:
Dial
611

ELECTRIC
BILL
Customer Support:
1-888-289-8988
24 Hour Pay By Phone:
1-866-441-4378
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Appendix F: Chapter Two Publication Permission
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Appendix G: Chapter Three Publication Permission
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Appendix H: Chapter Four Publication Permission
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Appendix I: Institutional Review Board Approval Letter
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Appendix J: Approved Informed Consent Form
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